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Abstract
Cerebral Malaria is a complex neurological condition that results from interac-
tion between the host and Plasmodium parasite through the different phases of par-
asite’s life-cycle. This interaction ranges from infection to the immune response
triggered in the host system. Various strains of the Plasmodium parasites are found
to have differences in the severity of disease after infection. However, the precise
factors defining the infectivity of Plasmodium parasites and the resulting disease
outcome have not been completely identified so far. In this thesis, the Plasmodium
berghei mouse model for Malaria is used to characterize the infection dynamics
of Plasmodium berghei ANKA (wild-type or WT) and a mutant strain that lacks
a Plasmodium antigen PbmaLS_05. It was found that the mutant infection leads
to lower parasitemia in red blood cells and less severe disease outcome in con-
trast to mice infected with the wild-type strain. Moreover, the mice infected by
injecting PbmaLS_05(-) KO-infected red blood cells show reduced immune re-
sponse in contrast to infection with PbmaLS_05(-) knockout (KO) -sporozoites.
By developing mathematical models describing various mechanisms of the infec-
tion and fitting them to experimental data; I find factors that influence the dif-
ference in disease progression seen between the two strains. Most strikingly, the
KO strain show a decreased ability to infect immature red blood cells that are
usually a preferred target of the parasite. This altered property of infection limits
parasite burden and affects disease progression. In addition to this, I performed
a statistical analysis of immune activation and immune response data from the
KO or WT infected mice, which resulted in selecting major indicators of cerebral
Malaria. The analysis showed that the number of CD8+ T cells accumulated in the
brain, the reduced proportion of CD8+ T cells to lymphocytes in the spleen, the
increased presence ofMalaria specific CD8+ IFN-γ+ T cells and the secondary ac-
tivation of CD8+ T cells due to the antigens cross-presented by infected red blood
cells sequestered in the brain are the prominent distinguishing factors between the
ECM causing PbANKA and non-ECM causing PbmaLS_05(-) infections. An ex-
ploratory analysis of the liver-stage of infection and immune response highlighted
that PbmaLS_05 may not have an important role to play in the triggered immune
response during the liver-stage of Malaria. However, its absence may lead to a
small decrease in number of productive infections during the liver-stage, which
must be further investigated. The antigen PbmaLS_05 can potentially aid in dis-
covering the factors that influence the activation of immune responses and that
might contribute to vaccine development and efficient parasite control.
Zusammenfassung
Zerebrale Malaria ist eine komplexe neurologische Erkrankung, die durch die
Interaktion zwischen dem Wirt und den verschiedenen Phasen im Lebenszyk-
lus des Plasmodium Parasiten ausgelöst wird. Diese Interaktion umfasst alles,
von der Infektion bis hin zur ausgelösten Immunantwort des Wirtssystems. Es
wurde festgestellt, dass verschiedene Plasmodium stämme sich in der Schwere der
Krankheit unterscheiden. Allerdings sind die genauen Faktoren, die die Infektiv-
ität des Plasmodiumparasiten und den Krankheitsverlauf bestimmen, bis jetzt noch
nicht komplett identifiziert. In dieser Arbeit wird ein Plasmodium bergheiMaus-
modell benutzt, um die Infektivität vonPlasmodium bergheiANKA (Wildtyp) und
eines mutierten Stammes, welchem ein Plasmodium antigen PbmalS_05 fehlt, zu
charakterisieren. Die Mutanteninfektion führt zu einer niedrigeren Parasitemie
in den roten Blutkörperchen und zu einem weniger schweren Krankheitsverlauf
im Vergleich zu Mäusen, die mit dem Wildtypstamm infiziert wurden. Außer-
dem zeigen die Mäuse, denen PbmaLS_05(-) KO-infizierte rote Blutkörperchen
injiziert wurden, eine reduzierte Immunantwort imVergleich zu einer Infektionmit
PbmaLS_05(-) KO-Sporozoiten. Durch das Entwickeln mathematischer Modelle,
die verschiedene Mechanismen der Infektion beschreiben, und das Fitten an ex-
perimentelle Daten, finde ich Faktoren, die den Unterschied im Krankheitsverlauf
der beiden Stämme, beeinflussen. Am auffälligsten ist, dass der KO Stamm eine
verminderte Fähigkeit aufweist, rote Blutkörperchen zu infizieren, welche nor-
malerweise das bevorzugte Ziel des Parasiten sind. Diese veränderte Eigenschaft
der Infektion limitiert die Parasitenlast und beeinflusst den Krankheitsverlauf. Des
Weiteren wurde eine statistische Analyse der Immunaktivierung und Immunant-
wort von KO oder WT infizierten Mäusen durchgeführt, die es möglich machte,
Hauptindikatoren für zerebrale Malaria auszuwählen. Die Analyse zeigte, dass
die Anzahl der im Gehirn akkumulierten CD8+ T Zellen, der reduzierte Anteil
von CD8+ T Zellen im Vergleich zu Lymphozyten in der Milz, die gesteigerte
Präsenz der malariaspezifischen CD8+ IFN-γ+ T Zellen und die sekundäre Ak-
tivierung von CD8+ T Zellen durch Antigenpräsentation von infizierten roten
Blutkörperchen, die sich im Gehirn ansammeln, wichtige Unterscheidungsfak-
toren zwischen ECM-verursachenden PbANKA und nicht-ECM-verursachenden
PbmaLS_05(-) Infektionen sind. Eine explorative Analyse des Leberstadiums
der Infektion und Immunantwort zeigte, dass PbmaLS_05 möglicherweise keine
wichtige Rolle in der ausgelösten Immunantwort während des Malaria Leberstadi-
ums spielt. Allerdings könnte dieAbwesenheit zu einem kleinenAbfall der Anzahl
von produktiven Infektionen während des Leberstadiums führen; dies muss noch
weiter erforscht werden. Das PbmaLS_05-Antigen kann potenziell helfen, die
Faktoren, die die Aktivierung der Immunantwort beeinflussen und die zu Vakzi-
nentwicklung und effizienter Parasitenkontrolle führen, zu identifzieren.
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Malaria is among the most serious tropical diseases affecting millions of lives
across the globe. A total of 93 countries in the African, Asian and Americas re-
gions are currently Malaria-endemic [1]. The incidence of Malaria is most fre-
quent among the poor who live in rural areas with little or no facilities for barriers
against Malaria. Therefore, Malaria is also called the epidemic of the poor. In
2016 alone, Malaria was responsible for 216 million clinical cases and an esti-
mated number of 445,000 deaths worldwide [1]. These huge numbers may well
be an underestimate owing to missing facilities for adequate reporting in the en-
demic regions. Malaria is a mosquito-borne disease and is caused by the protozoan
parasite Plasmodium. It is characterized by acute anemia which in severe cases re-
sults in respiratory disorders or permanent brain damage. Too late interventions
may also cause death. Cerebral Malaria, a leading cause for mortality in Malaria,
is characterized by coma and long-term neuro cognitive impairments in the sur-
viving patients [2]. It is caused by Plasmodium falciparum, the most prevalent
and lethal Malaria parasite affecting humans.
There have been several efforts towards Malaria control since the last century.
To name a few, the emergence of special insecticides in the 1930s and the discov-
ery of the first anti-Malarial drug Chloroquine in the 1940s. More recent work has
been in advancement of insecticide-treated bed nets, reduction of mosquito popu-
lations by biological control and creations of vaccines. Of the vaccines currently
under consideration, the RTS,S is the most developed but suffers from poor effi-
cacy [3]. Other vaccines that are still in the early phases of development include
the genetically attenuated parasite (GAP) malaria vaccine [4] and the transmission
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blocking vaccines (TBV) targeting the transmission of parasites from mosquito to
humans [5]. In-spite of remarkable progress in fighting Malaria, the emergence
of multi-drug resistant strains in recent years has marred the various programs to-
wards Malaria eradication [6]. Therefore, more efforts in the formulation of treat-
ment strategies that instead of targeting the parasite, aim at weakening underlying
disease mechanisms are required for effective Malaria control. For designing such
strategies, a complete understanding of Malaria pathogenesis is desirable, many
aspects of which are still unknown. For example, it has been observed across vari-
ous Plasmodium strains that some strains cause only less severe symptoms and are
treatable, whereas others trigger serious health impacts [7]. Identifying the factors
that shape the extent of harm caused by a strain can be potentially explored to de-
velop newer drugs and searching vaccine targets [7]. Such factors that eventually
decide the fate of disease can be related to any stage of the parasite cycle. In the
following sections, the life-cycle of Plasmodium is described. This is followed by
the discussion on observed varying levels of severity of disease caused by differ-
ent Plasmodium strains. Next, the experimental observations that motivated this
thesis are introduced. Towards the end, the implications of these observations and
why they lead to the investigation of various stages of the disease are elaborated.
1.1 Life-cycle of the Malaria parasite
Plasmodium lives inside multiple hosts along-with different within-host stages
during its lifetime. Its complex life cycle can be broken down into two events:
the parasite takes a motile form to go from one location to the other (from one
host to the other or one organ to the other inside a host), and once inside the de-
sired location, transforms into a replicative, growing form. This sub-cycle repeats
three times over the life cycle the malaria parasite [8]. When an infected mosquito
bites a vertebrate host, parasites in the form of sporozoites are released from the
mosquito’s salivary gland into the host, after which the sporozoites travel to the
liver. Inside the liver, the parasite replicates by infecting hepatocytes, that burst to
release tens of thousands of merozoites marking the end of the liver stage. These
merozoites are released into the bloodstream where they infect red blood cells
(RBCs). Inside an iRBC, the parasite undergoes asexual reproduction to release
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FIGURE 1.1 The life cycle of Plasmodium
Mosquitoes transmit sporozoites to the host. These sporozoites infect liver
cells, where they mature to form schizonts. The infected liver cells burst to
release merozoites that infect the red blood cells. In the blood, the parasite
reproduces asexually to produce more merozoites that further infect other red
blood cells. Some of the merozoites develop to form male or female gameto-
cytes that are taken up by mosquito during a blood meal. The gametocytes re-
produce sexually inside the mosquito to produce sporozoites. This figure has
been reproduced and modified with permission from Bbkkk [CC BY-SA 4.0
(https://creativecommons.org/licenses/by-sa/4.0)]
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more merozoites that infect other uninfected RBCs finally causing anemia in the
host. A proportion of the blood-stage parasites differentiate into male and female
gametocytes. These gametocytes reach the mosquito that takes a bloodmeal on the
infected host. The gametocytes develop into gametes that fuse in the mosquito’s
gut to produce a zygote, that in turn develops into oocyst, inside which thousands
of sporozoites are produced that migrate to the salivary glands, thereby continuing
the cycle again [9].
1.2 Malaria parasites show heterogeneity in disease
outcomes
It has been found that the Plasmodium parasite strains exhibit a broad variation
in the extent to which they harm their hosts and the way in which they do it. Plas-
modium vivax is known to cause Malaria in humans that is relatively benign and
rarely results in life threatening consequences. Whereas, Plasmodium falciparum
infections in humans are often of the severe kind, for example, cerebral Malaria
or pregnancy related Malaria in which both the mother and fetus are in danger.
Mouse models are often used to mimic Malaria infection in humans, in order to
answer questions that cannot be answered by observing an infected human [10].
Most common mouse models include infection by a parasite called Plasmodium
berghei. Of these, P. bergheiANKA causes experimental cerebral Malaria or ECM
and leads to death in mice, whereas P. bergheiNK65 causes liver injury and is also
lethal [11]. Investigating such contrasting infections has proven useful in outlining
various factors that contribute to severity of disease [12–14].
1.3 Deletion of a specific gene abrogates the
development of experimental cerebral Malaria in
mice
PbmaLS_05 is a Plasmodium gene that has been conserved through evolution.
It is present in all of the human and rodent Plasmodium strains. This gene localizes
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to the apicoplast, an organelle that is an endosymbiotic relict of the parasite. The
researchers at the Centre for Infectious Diseases, Parasitology Unit, University
Hospital Heidelberg deleted this gene and investigated the PbmaLS_05 (-) (KO)
strain in comparison with the PbANKA (WT) strain [13]. It was observed that
deleting the PbmaLS_05 had hardly any impact on the life-cycle, but it altered
the expected severe disease outcome. The mice infected with the developed KO
did not develop ECM. These results were unchanged when the mice were infected
through two different modes of infection, namely via sporozoites or infected red
blood cell (iRBC). The precise reasons for the altered pathogenic outcome of Pb-
maLS_05 (-) KO parasites could not be deduced from the experimental data alone.
It requires testing of various biologically plausible hypotheses that can explain the
observations. The complex parasite life-cycle tells us that there are many possi-
ble events in the progression of the infection where this growth defect may result
in less severe disease outcomes. In the following sections, such hypotheses are
discussed.
1.4 Varying Plasmodium strains posses a wide range
of infectivity during the blood-stage
The blood-stage of the Plasmodium parasite is responsible for the clinical
manifestations of Malaria. Thus, most of the variations in disease outcomes
among various strains arise from differences in blood-stage infection character-
istics [12, 15–19]. In humans, Plasmodium vivax restricts invasion only to young
red blood cells [20]. Plasmodium berghei in mice prefers to infect young RBCs,
whereas for others it is equally likely to infect cells of different age groups. In
addition to RBC age, the parasite strains may also differ in other blood-stage in-
fection properties including rate of infection, the time taken for an infected RBC
to mature or production rate of merozoites from a mature infected RBC. All of
these above characteristics must be shaped by the benefit that the parasite gains
from them. For example, it has been proposed that restricted infection of younger
RBCs is advantageous to the parasite to self-regulate and not cause excessive harm
to the host, thereby increasing its chances of transmission [21]. However, this also
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means, that against such infections, temporary reduction of RBC production may
help the host to recover [14, 22]. On the other hand, an increased preference for
young red blood cells or reticulocytes has been related to highest parasite densities,
producing severe anemia [22]. Thus, restriction or preference of particular RBC
age appears to be a strong contributor to decide fate of the disease. This leads
to the hypothesis that PbmaLS_05 (−) KO parasites fail to cause ECM because
of altered infection characteristics, particularly in relation to RBC age during the
blood-stage. Comprehending which of the infection characteristics are altered and
quantifying their impact on resulting infection is a major part of this thesis.
1.5 Liver-stage development is strongly linked to
nutrient availability
Availability of a conducive environment and adaptability of Plasmodium to it
are the key factors governing overall fitness of the parasite during the life-cycle
through multiple hosts and multiple organs within the host [8]. Once the motile
form of the parasite, the sporozoite, reaches the host liver and enters a hepato-
cyte, it changes into a reproductive form called the liver-schizont, that undergoes
multiple divisions. This division rate is one of the fastest growth rates among
eukaryotic cells [8]. During such extreme activity, in spite of having its own
metabolism, the parasite additionally scavenges a variety of nutrients and metabo-
lites from the host cell [23,24]. In fact, genetically obese (fa/fa) Zucker rats were
observed to have four fold higher number of parasitized hepatocytes than the lean
Fa/fa control rats [25]. In vivo murine experiments that studied the effect of host-
starvation on Plasmodium liver-stage development found that the starved mice
showed more than 10-fold increase in parasite load on infection than the normal-
fed and infected mice. The parasites in the starved case, showed both an increased
size and increased survival rate [26]. Under starvation, a proportion of cells un-
dergo canonical autophagy, that is nothing but self-digestion of parts of the cyto-
plasm, thereby releasing amino acids and sugars into the environment. Prado et
al. hypothesize that as a result of the triggered canonical autophagy in the livers
of starved hosts, the intra-hepatic parasite experience a nutrient abundant envi-
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ronment, thus increasing in size and surviving better due to reduced competition
for nutrients [26]. In another study, mice deficient in a key autophagy promoting
protein, ATG5, were found to produce significantly smaller parasites when in-
fected with Plasmodium yoelli 17X, hypothesizing that growing parasites utilize
the autophagic pathway as a source of nutrients [27]. This strongly supports the
correlation between parasite development in the intra-hepatic stage and nutrient
availability.
In the PbmaLS_05 gene experiment, number and size of the parasite in its
liver-stage form were quantified in vitro [13]. The data suggests that absence of
PbmaLS_05 has no effect on the number or developmental size of intra-hepatic
parasites, in vitro. However, a slight developmental delay was observed for KO
parasites during the early time points of hepatic infection. It is probable, that this
difference observed in vitro is pessimistic, and the KO parasite growth is addition-
ally retarded in vivo. The apicoplast is known to play an important role in fatty
acid synthesis as well as scavenging from degraded host cell material [28,29]. The
fact that PbmaLS_05 localizes to the apicoplast [13] makes it highly probable that
PbmaLS_05 contributes in parasite nutrition synthesis. Thus, a possible reason for
the observed developmental delay could be that PbmaLS_05 gene plays a role in
secondary nutrition pathways, the scavenging of nutrients as well as metabolites
from the host cell cytoplasm. As this is not explicitly required for the development
of the parasite, the KO parasite successfully completes the life-cycle, but remains
smaller sized and lesser in number than the WT parasite.
1.6 Cerebral Malaria and its yet unknown
pathogenesis
Of the total Malaria cases that culminated in death in the year 2016 [1], ∼ 13%
were due to cerebral Malaria (CM) [30]. Cerebral Malaria, caused by Plasmodium
falciparum in humans, is the most severe outcome of Malaria. It is a neurologi-
cal complication, characterized by coma with high mortality rate, and long-term
neuro-cognitive impairments in the surviving patients [2]. Available treatment
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FIGURE 1.2 Overview of the thesis
Different stages of Malaria and the specific characteristics that are the focus of the
thesis. These characteristics are used to compare the two murine strains PbANKA
WT and PbmaLS_05(-) KO during the various within-host stages of Malaria.
New treatment strategies can be developed by understanding the not yet precisely
known pathogenesis of cerebral Malaria. So far it has been established that imbal-
ance of pro- and anti-inflammatory immune response to Malarial infection is the
primary cause of cerebral pathology, however, the exact processes in the infection
dynamics that cause this imbalance and their complex interactions are largely un-
known [33]. Plasmodium berghei ANKA infection in C57BL/6 mice is a mouse
model often used for experimental cerebral Malaria (ECM) [34]. The observations
from the PbmaLS_05 (-) (KO) parasite show that although the KO-infected mice
do not develop ECM, there is a difference in the immune activation and migra-
tion of immune cells to the brain between the KO-iRBC-infected mice and KO-
sporozoite-infected mice. Whereas, the PbANKA WT-infected mice consistently
showed similar levels of immune activation and migration irrespective of the route
of infection. The experimentally measured number of various immune cell types
and their proportions in spleens and brains from these differently infected groups
of mice can be effectively used to understand, which of these cell-types play a
key-role in the development of ECM.
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1.7 Mathematical models for within-host Malaria
infection dynamics
It is essential to establish factors that are involved in a disease, however, this
alone is not enough. Quantification of the extent of a factor shaping the outcome
of a disease is important as well [35]. This belief drove Ronald Ross to develop
a mathematical model, known as the ’Ross model’. This was an epidemiological
model that demonstrated the relationship between the number of mosquitoes and
the incidence of Malaria in humans [36]. For many years, model-based testing
of mechanistic hypotheses, has been used to study infectious diseases. In Malaria
too, several mathematical models exist that model the within-host parasite and its
interaction with the host. These models are instrumental in explaining the exper-
imental observations by assuming a plausible hypothesis, for example, preferred
specific targets by particular parasite strains [7,12,19], effect of treatment [37,38],
elicited immune response [39, 40]. As parasitemia in Malaria is associated with
its blood-stage within the host, the blood-stage remains the most modeled stage
in the field. These models are designed to track the parasite replication in red
blood cells, the red blood cell turnover and the resulting parasitemia. Depending
on the kind of theoretical hypothesis being tested against experimental observa-
tions, these models may range from the more basic, as a system of ODE equations
of standard viral replication [41] to more recent, powerful and complex partial
differential equations in applications where the effect of red blood cell age on
infection dynamics is being explored [12,19,22,42]. Some models are further ex-
tended to include response to drug [43] or immune responses triggered during the
blood-stage [44]. On the other hand, the number of mathematical models for the
liver-stage is very limited. Other than some models, that consider the interaction
between transmission and liver-stage [45] or liver-stage and blood-stage [46, 47],
this area is highly unexplored, possibly due to the limitations in gathering data
during the liver-stage [48]. No model that incorporates the role of available nutri-
ents and host-autophagy on intra-hepatic development of Plasmodium was found.
As the information on pathogenesis of cerebral Malaria is still limited, the use of
mathematical models or advanced statistical methods to acquire a theoretical un-
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derstanding of this immune response related severe disease outcome is missing.
There are some studies that quantify the sequestered RBC population during the
blood-stage of Malaria that can be considered pre-cursors to the onset of cerebral
Malaria [49], but more recent studies that tackle this problem with a mathematical
model are unavailable. Machine learning is another effective tool for statistical
inference in problems where instead of modelling a hypothesis, the computer is
made to infer a relationship between variables in a dataset [50]. In Malaria, the
use of machine learning is restricted to mostly image analysis in Malaria diagno-
sis [51–53] and rarely to other applications, for example, discovering drug combi-
nation therapies using large clinical datasets [54]. But this technique hasn’t been
explored to decipher Malaria pathogenesis, mainly due to the lack of large datasets
from lab experiments.
1.8 Outline of the thesis
My thesis aims at modeling the infection dynamics of two Plasmodium strains
on the basis of experimental data at various stages of the disease. The first strain
is the wild-type Plasmodium berghei ANKA, which when used to infect C57BL/6
is a mouse model for experimental cerebral Malaria. The other is the knock-out
PbmaLS_05(-) that was observed to not cause cerebral symptoms inmice [13]. The
available data itself, are not sufficient to determine which factor exactly shapes
the disease outcome and to what extent. This limitation is overcome by using
mathematical modeling to test various plausible hypotheses. By understanding the
differences in the disease dynamics between the two strains using various models,
further conclusions can be drawn towards the pathogenesis of Malaria. With this
goal, the thesis is structured into the following chapters.
In Chapter 2, the experiments and the observed data are described in detail.
The common technical methods related to modeling throughout the chapters are
explained.
Chapter 3 describes the blood-stage infection dynamics model that is based on
the red blood cell turnover model [55] and infection model from [12]. In this chap-
ter, I discuss how the combined model is insufficient in describing the intended
data, and modifications to RBC turnover due to the onset of Malaria are required
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to fully explain the observations. In addition, distinct infection parameters for the
two strains are estimated and compared to reveal which of the two strains has a
higher preference for young red blood cells or reticulocytes.
The scope of Chapter 4 is similar to Chapter 3, however the data to be modeled
here is from themice that were treatedwith phenylhydrazine and then infectedwith
the respective strains. Phenylhydrazine is a drug used to induce artificial anemia
in lab animals. Therefore, in this Chapter, the changes to the erythropoietic system
because of the treatment is modeled. With this treatment model, and the infection
parameters from Chapter 3, the resulting infection dynamics in treated animals is
predicted and discussed.
Chapter 5 is a proof of concept study that investigates the potential role of
nutrition availability during the liver-stage parasite development via a liver-stage
mathematical model for parasite dynamics in the liver-stage. For such an inves-
tigation, an extreme example of parasite development under nutrition abundant
conditions was needed, therefore the experimental data from [26] were used to
design the model. This Chapter highlights the correlation between parasite repli-
cation and environmental nutritional status and the fact that minor differences in
the number of parasites seen between the WT and KO during the liver-stage could
potentially lead to major differences in the parasites that egress to blood-stage.
Chapter 6 focuses on a novel application of a simple machine learning algo-
rithm to highlight the distinct levels of immune activation and immune sequestra-
tion in mice infected by one of the two strains. The model is based on the observed
immune response activated in the spleen and sequestered immune cells in the brain
on day 6 post initiation of the blood-stage. This Chapter sheds light on the under-
lying immune mechanisms and motivates protocols for future experiments.
Chapter 7 summarizes the findings of the thesis and puts everything into con-
text of the fundamental question, what potentially changed in the KO infection
dynamics, that it failed to cause cerebral Malaria in mice (see Fig. 1.2 for an
overview).
Some sentences of the introductory paragraph of this chapter are reproduced from [56], which





In this chapter, I describe the experimental protocols, the observed data and
techniques used for model fitting and parameter estimation. As the thesis in-
volves modeling disease dynamics during various within -host stages of Malaria,
the chapter has been sectioned on the basis of stages of Malaria, I present the ma-






2.2.1.1 Experiment on untreated mice
In this experiment, two groups of C57BL/6 inbred mice were infected with
106 infected red blood cells (iRBCs) intravenously on day 0 (start of the experi-
ment). The iRBCs used were obtained from mice infected with wild-type PbGFP
Luccon (P.berghei line 676m1c11) (WT), a GFP-luciferase transgenic derivative of
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FIGURE 2.1 Experiment on untreated mice
(A). C57BL/6 mice were infected with 106 iRBC of PbANKA (WT), PbmaLS_05
(-) (KO) or left uninfected. Samples of 10 µl blood were drawn daily to measure
the concentration of RBC (cells/µl), reticulocyte proportion (in % of RBC) and
parasitemia (in % of RBC). (B). Measured concentration of RBC (cells/µl), retic-
ulocyte proportion (in % of RBC) and parasitemia (in % of RBC) for each of the
three groups.
P. berghei ANKA [57], or the mutant PbmaLS_05 (-) parasites (KO) generated in
the wild-type PbGFP Luccon strain [13]. A group of naïve control mice consisted
of uninfected mice that were of similar age ranges as the two infected groups. 10
µl of blood samples were taken daily from all the mice from day 0 until day 4
post infection (p. i.). The total red blood cell count, reticulocyte proportion in
every 100 red blood cells and parasitemia defined as proportion infected red blood
cells in every 100 red blood cells were measured from the daily blood samples.
The RBC count was measured using a Coulter counter and reticulocyte propor-
tion were measured via FACS analysis of CD71 CD71-PE, eBioscience, Clone
R17217) labeled reticulocytes. FACS analysis was used to determine GFP posi-
tive infected red blood cells to quantify parasitemia. A sketch of the experimental
protocol is shown in Fig. 2.1 Mice were sacrificed at day 5 p.i., when mice in-
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FIGURE 2.2 Experiment on Phenylhydrazine (PHZ) treated mice
(A). Mice were pre-treated with one dose of 40 mg/kg PHZ on each of two days
before infection. The mice were then infected with with 106 iRBC of WT or KO
parasites on the following day. One group (n=3) was left uninfected. 10 µl blood
samples were taken daily and analyzed. (B). Measured concentration of RBC
(cells/μl) and reticulocyte proportion (% of RBC) for each of the three groups.
2.2.1.2 Experiment on Phenylhydrazine (PHZ) treated mice
As an extension to the experiment described in Subsection 2.2.1.1, three groups
of mice were treated with two doses of phenylhydrazine (PHZ, 40 mg/kg), on
two consecutive days. Two of these three groups were infected with 106 iRBC
obtained in the same way as described in Subsection 2.2.1.1, whereas the third
group were kept uninfected as PHZ treated control. 10 µl samples of blood taken
from each mouse, everyday, from day of infection to day 5 p.i. were analysed for
total RBC count, reticulocyte proportion and parasitemia using methods explained
in Subsection 2.2.1.1. A sketch of the experimental protocol is shown in Fig. 2.2.
The mice were sacrificed on day 6 p.i..
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FIGURE 2.3 Experimental protocol for the liver stage
C57BL/6mice in four groups of 3mice eachwere infectedwith 2×105 sporozoites.
Each of the groups of mice were starved for 24h or 36h or 12h prior to infection
and 24h post infection or were fed normally (control) [26]. The size and number
of parasites in the liver were measured by removing the livers at 40h post infection
and analyzing their histology.
The data used for this part of the thesis is completely based on the experi-
ments done by Prado et al [26]. In this experiment, C57BL/6 mice were infected
with 2 × 105 sporozoites of PbmCherryhsp70+Luceef1α P. berghei-ANKA. The
mice were divided into 3 groups with different starvation regimes: a control group
feeding ad libidum, fasted for 24 h or 36 h or 12 h prior to infection and 24 h post
infection via sporozoites (termed as 36h pre-starved). At 40 hpi livers of all the
mice were removed and their histology analyzed by staining sections of the liver
with hematoxylin and eosin (H&E) to measure parasite numbers and parasite size
using bioluminescence imaging. In detail explanation of the methods can be found
in [26]. The experimental protocol is represented in Fig. 2.3.
2.2.3 Cerebral inflammation
Two groups of 5 C57BL/6 mice each were infected with P.bergheiANKAWT
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FIGURE 2.4 Experimental data for the liver stage
C57BL/6mice in four groups of 3mice eachwere infectedwith 2×105 sporozoites.
Each of the groups of mice were starved for 24h or 36h or 12h prior to infection
and 24h post infection or were fed normally (control). The number (A). and size
(B). of parasites in the liver were measured by removing the livers at 40h post
infection and analyzing their histology. Experiments were repeated 3 to 5 times
(error bars show SD) [26].
kept uninfected as a control group. All the mice were sacrificed on day 8 p.i..
The brains and spleens of these mice were harvested and the lymphocytes were
isolated. A part of the lymphocytes were also stimulated ex vivo with parasite-
derived Pb1 of GAP50 (SQLLNAKYL) epitope [58]. All the cells were stained
for CD8+, CD4+ and IFN-γ. Quantification and phenotypic analysis of T cells
was done by flow cytometry.
In a separate set of experiments, two groups of 5 C57BL/6 mice each were in-
fected with P.berghei ANKAWT or PbmaLS_05 (-) strains via infected red blood
cells (obtained as stated in Subsection 2.2.1.1) injections, and a group of 5 mice
was kept uninfected as a control group. All the mice were sacrificed on day 5 p.i..
The spleens and brains of these mice were harvested and CD8+, CD4+ and IFN-γ
numbers and proportions were recorded as in the experiment with sporozoite in-
fection mentioned earlier in this Subsection. For more details on the methods used
refer [13].
17
2.3 Mathematical Models and Parameter Fitting
The implementation of mathematical models and there analyses was done in
the R language of statistical computing [59]. The age-structured model of RBC
aging and anemia dynamics was compartmentalized to form a tractable system of
ordinary differential equations with gamma-distributed lifetimes for RBC andmat-
uration times for infected RBC [12]. A compartment length of 4h was used in these
models. The deSolve R package was used to solve differential equations [60]. The
models were fitted to the data using ’optim’ fitting function in R. In places where
the fitting algorithms failed to converge due to a strong correlation between the
parameters, a parameter sweep was performed to find sets of parameters that fit
the data. All proportion data (parasitemia levels and proportion of reticulocytes)
were logit- transformed to allow residuals that are normally distributed residuals.
Data from the infected groups were scaled relative to the control data. The resid-
ual sum of squares scaled by the number of data points, also known as the average
Residual Sum of Squares (aRSS) was calculated to evaluate model performances.
The 95%-confidence intervals were assessed by profile likelihood analysis.
2.4 Classification with logistic regression
In Chapter 6 I will use logistic regression to determine the most significant
variables in deciding a categorical outcome. Here the theory of logistic regression
is explained.
Consider a set of n observations D such that D = {d1, d2, . . . , dn}. Each di
consists of two parts di = {xi, yi}. xi is a vector of m covariates or features and
yi is a categorical outcome vector with Y possible outcomes that are dependant
on xi. When the classification is for binary class levels, Y can take the value 0
(negative class) or 1 (positive class). A future x with unknown corresponding y is
classified as 0 or 1 by a prediction rule built by learning D. Here, the prediction
rule is modelled using logistic regression.
















The logistic regression model takes the form of Eq. 2.2 [61], where
xi = (xi1, xi2, . . . , xim) is the feature matrix, with a feature size of m and
β0, β1, . . . , βm are the (1 + m) weight coefficients for the intercept and the m
features. The probability p(y = 1|xi) represents the probability that the ith sample
is from class 1. The default decision threshold is at 0.5.
ŷi =
1; for p(y = 1|xi) ≥ 0.50; for p(y = 1|xi) < 0.5 (2.3)
One concern in fitting such models to data is selecting a subset of predictors that
are just enough to explain the dependant variable. Also, in datasets with many
correlated variables, the weights are poorly determined and the model exhibits
high variance. A very large positive coefficient or weight on one variable can be
cancelled by an equally large negative coefficient on the other correlated variable.
In such cases, Lasso regularization (see Eq. 2.4) can be used that constrains the
size of coefficients during the fit and ensures that over-fitting is avoided thereby
making the resulting model easy to interpret. In Eq. 2.4, λ is the regularization
term, a hyper-parameter of the logistic regression fit.













2.5 Classifier Performance Metrics
The performance of this logistic regression based classifier is quantified using
a 2 x 2 confusion matrix as shown in Table 2.1 [62].
The numbers along the major diagonal represent the number of observations
correctly classified (given a threshold τ ), and the numbers off this diagonal repre-
sent the errors. True positive (TP ) is the number of positive observations classified
as positives, whereas true negative (TN ) is the number of negative observations
classified as negatives. Additionally, false positive (FP ) is the number of obser-
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vations that are incorrectly classified as positive and false negative (FN ) is the
number of observations that are incorrectly classified as negative. Accuracy of
the classifier for a total of N number of observations defined as:
ACC = TP + TN
N
(2.5)
Other performance indicators are sensitivity (SEN ) that measures the propor-
tion of positives that are correctly classified while specificity (SPEC) measures
the proportion of negatives that are correctly identified. As the decision threshold







2.6 Receiver operating characteristic (ROC) curve
The ROC curve is a two-dimensional curve in which true positive rate or sensi-
tivity is plotted against false positive rate or 1-sensitivity. Such a graph represents
the tradeoffs between benefits (true positive) and costs (false positive). The ROC
curve is therefore a tool to set classifier thresholds depending upon the goal of
setting up the classifier in the first place. Some applications may demand a higher
sensitivity with negotiable specificity whereas some may aim for a higher speci-
ficity with negotiable sensitivity. The area under the ROC curve (AUC) ranges






Within the host, Plasmodium parasites follow a complex life cycle involv-
ing parasite replication and differentiation in liver and blood [64]. Pathogene-
sis of malarial disease is mainly associated with the blood-stage of the parasite
life-cycle [65] as parasite infection and lysis of infected RBCs causes anemia, the
main symptom characterizing a malarial infection [66]. It has been suggested in
many studies that different parasite strains show varying RBC age-specific target
preference [12, 15, 16, 19, 22]. Infact, the preference for anemia -induced, newly
produced reticulocytes demonstrated by some parasite strains has been implicated
in elevated parasite density and severe disease outcomes [67]. In this chapter, I use
a combination of experimental data and mathematical models to investigate para-
site blood-stage infection dynamics. The model accounts for rate of erythropoiesis
and its dependence on the changing peripheral RBC concentration, the reduction
in erythropoiesis following a malarial infection and the replication and multiplica-
tion of the parasite in the RBC pool. Using this approach, I determine if specific
target preference during the blood-stage could be a possible factor in contributing
to different disease outcomes between the PbANKA (WT) and PbmaLS_05 (-)
Some sentences and most of the figures of this chapter are reproduced from [56], which were




3.2.1 Mathematical model for erythropoiesis
To design a mathematical model of the blood-stage infection dynamics for
Malaria that accounts for RBC age, I take a bottom up approach. Here, I begin
with establishing a model for erythropoiesis on the lines of the model proposed
in [68]. In this age-structured model, a system of coupled ordinary differential
equations tracks population density of RBCs of age τ at time t. The model divides
the lifespan of an RBC, τRBC into n equal segments or compartments, each of
duration h, such that n = τRBC/h. The density of RBC in total blood volume for
the ith compartment is represented by xi(t) (where, i = 1, . . . , n). The production
of RBCs takes place at the bone marrow constantly and senile RBCs are removed
from circulation, and thus a level of optimal RBC concentration is maintained in
the blood. Apart from this, RBCs are lost by a loss-rate of 1/τRBC from each
compartment, such that almost 85% of RBCs are lost until they reach the maximal
lifespan τRBC . A Hill function governs the feedback between RBC concentration
at circulation at a time t, given by X(t) and the production new RBCs that enter
circulation at time t + T , where T is the total feedback delay. The Hill function is
parameterized by themaximal production rate of RBCs in the bonemarrow,F0, the
concentration of peripheral RBC concentration θ0 at which the production of RBCs
is at half the maximal limit, the Hill coefficient k. The Equations (3.1) …(3.3)
simulate the process of erythropoiesis. These equations represent a mean-field
approximation of the originally developed system relying on partial differential
equations, thereby transforming assumed fixed, constant lifespans of RBC into
















































FIGURE 3.1 Model sketch: infection dynamics at the blood-stage
The young RBCs (reticulocytes) are produced in thebone marrow and released to
circulate in the body. While circulating, the RBCs (denoted in red circles) age upto
τRBC after which they perish. An infectivity profile β(τ) denoting the different
rates of infection specific to reticulocytes and normocytes is shown by the blue
curve. It is assumed that the strain infects reticulocytes with an infection rate
(β0×RF) that is higher than the normal infection rate of β0 by a factor RF. When
infected, an RBC undergoes maturation and bursts to release many merozoites.





3.2.2 Mathematical model of blood-stage infection dynamics
The erythropoiesis model is extended to include blood-stage Malaria infection
on the basis of the work done previously in [22] and [12]. The circulating unin-
fected RBCs are infected at an age dependant infection rate βi by potent merozoites
at time t, z(t). On infection, the RBC houses the multiplying merozoite to eventu-
ally burst after time tm releasing m free merozoites that each finds an uninfected
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RBC to attack and continue the infection cycle. The merozoites last an average
time duration of 1/dm, after which they perish without leading to a successful in-
fection. The infected RBC concentration per blood volume, Y (t) is also sectioned
into g compartments by age such that g = tm/h yielding yi(t), i = 1 . . . g. Such
a compartmentalization leads to a gamma distributed iRBC maturation time as in
the case of uninfected RBCs, but with a mean tm. The infection rate βi is defined
with respect to RBC age. For reticulocytes, the infection rate increases by a factor
RF called the reticulocyte factor, whereas for normocytes, the infection rate is
solely defined by β0 (see [19] and Eq.(3.9), where τReti denotes the age at which
a reticulocyte matures into a normocyte). The Equations (3.4) …(3.8) mathemat-















































βi(t)z(t)xi(t) − dmz(t) (3.8)
βi =
β0RF i ≤ τReti/hβ0 i > τReti/h (3.9)
(3.10)
3.2.3 Average infectivity and reticulocyte preference
Here, I define another term called average infectivity β, which is the infec-
tion rate of a merozoite during blood-stage infection. The average proportion of
reticulocytes in total RBC population at steady state in mice is 5.8 %. Hence, the
average infectivity accounting for the proportion of target cells that have a higher
rate of getting infected by a factor RF , is given by β = β0(0.058RF + 0.942).
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In order to quantify age-specific target preference of a given parasite strain, we
formulate reticulocyte preferenceRP which is a ratio of infected reticulocytes per
100 reticulocytes to infected normocytes per 100 normocytes. Thus, if R and IR
define the concentration of reticulocytes and infected reticulocytes, respectively,
and N and IN the corresponding concentrations for normocytes, the reticulocyte
preference is calculated by RP = (IR/R)/(IN/N). The reticulocyte factor is a
unit in the mathematical system to specify infection dynamics, whereas the retic-
ulocyte preference can be obtained from experimental observations.
3.3 Results
3.3.1 Characterizing the dynamics of erythropoiesis and
determining reticulocyte maturation times in the blood
The model presented in Equations (3.1)-(3.3), [55], [68] is fitted to the ob-
served dynamics of RBC concentration in uninfectedmice by sampling 10µl blood
every day for five days (Fig. 2.1). Bleeding leads to a decrease in RBC concentra-
tion which in turn leads to increased production of fresh RBCs in the bone marrow
to counter the loss. This feedback is delayed by time T . The feedback thus trig-
gered is a direct consequence of anemia and its extent depends on the severity of
anemia, here modelled with a Hill function [68]. Setting the maximal lifespan for
RBC τRBC at 40 days [69] and Hill coefficient of k at 7.6 [68], other parameters in
the model are estimated. The resulting estimates of maximal RBC production rate
F0 = 5.95 × 104 cells µl−1h−1 [4.02, 6.82] and the RBC concentration at which
the production rate is half the maximal θ0 = 6.65 × 106 cells µl−1[5.28, 6.84], ap-
proximately 95 % of the RBC concentration at steady state. After testing possible
feedback delays of T = 0, 1, 2, and 2.5 days, it was estimated that novel RBCs
from the bone marrow enter circulating blood after a lag of T = 2 days. All
the estimates are in agreement to previously determined parameters for erythro-
poiesis in mice [55], [68] (see Figure 3.2 and Table 3.1). As the focus of this study
is understanding the dissimilarity between reticulocyte dynamics and normocyte
dynamics, establishing the parameter τReti, the maturation time of a reticulocyte















































FIGURE 3.2 Change in RBC concentration as estimated by erythropoiesis model and
estimation of reticulocyte age
(A) The plot shows the measured concentration of red blood cells for naïve mice
(mean ± SD, n = 3), as well as the dynamics predicted by our model (best fit-
red solid line, 95%-confidence interval- shaded area) using parameter estimates
for RBC turnover and reticulocyte production as given in Table 3.1. (B) Based
on model predictions and the measured proportion of reticulocytes on day 0, we
consider a maturation time for reticulocytes of τReti = 36 h
predictions for different RBC age compartments were compared to the observed
mean proportion of reticulocyte in the experiment (Figure 3.2 B) and τReti was
estimated to be 36 h or 1.5 days which is in accord with estimates between 1 and
3 days found in [70], [71], [72].
3.3.2 Parasite-induced cell death cannot explain the observed
loss in reticulocyte proportion
On examining the experimental data from P.berghei ANKA (WT) or Pb-
maLS_05 (-) (KO) infected mice, it is clear that there is a considerable decline in
the proportion of reticulocytes around day 3 post infection. This decline is accom-
panied by an increase in parasitemia (Figure 2.1). The difference in parasitemia
is also visible between the two strains as infection progresses, reaching its peak
when WT mice show the first signs of ECM (around day 4 p.i.) with the KO only
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FIGURE 3.3 Homeostatic erythropoiesis does not explain the observed dynamics
The observed dynamics of the proportion of reticulocytes (A) and parasitemia (B)
for WT (black) and KO (grey) parasites are shown. Colored lines indicate the
predictions by the mathematical model assuming normal erythropoietic feedback
conditions as described by Eqs. (3.1)-(3.8) with different values for the infection
rate β0 (mz−1µl−1 h−1). Such a model is not able to explain the simultaneous
decrease in the reticulocyte proportion and increase in parasitemia around day 3
post infection.
eliciting half the parasitemia as compared to the WT (0.29 ± 0.03 % KO com-
pared to 0.63 ± 0.05 %WT) (Figure 2.1). The erythropoiesis model is augmented
to incorporate infection dynamics (see Equations (3.4)-(3.9)). The model assumes
that the average lifespan of a merozoite of 1/dm = 30 min [73], a maturation time
of an iRBC of tm = 24 h [74, 75] and that an infected RBC releases on average
m = 9 merozoites after bursting [74–76]. With these assumptions, on simulating
the model outputs for various β0 and RF combinations, it is found that the plung-
ing reticulocyte proportion around day 3 p.i. cannot be explained by the increased
parasitemia using the estimated erythropoiesis parameters in Table 3.1. This ob-
servation holds even when assuming a disproportionately high infection rate β0
or extremely high reticulocyte factor RF (see Fig 3.3). In summary, the decrease
in reticulocyte proportion cannot be accounted for by a preferential reticulocyte
parasitizaion over that of the normocytes.
It is known that malaria not only causes loss of erythrocytes to parasitization,
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TABLE 3.1 Estimated parameters for erythropoiesis, disease induced feedback modula-
tion and fixed parameters for parasite infection
Estimated parameter values describing erythropoiesis in mice based on the model
as described in Equations (3.1)- (3.9)
Parameter Description Unit Value References
ERYTHROPOIESIS








θ RBC concentration at








T Delay in RBC produc-
tion feedback
days 2 [68]
τReti Maturation time of
reticulocytes in the
blood
hours 36 [71, 72]









t0 Time at which half of





tm Maturation time of
iRBC
days 1 [74, 75]








TABLE 3.2 Parameter estimates for parasite infectivity comparing PbANKA (WT) and
PbmaLS_05(-) (KO).
Only the ranges of parameters are added to the table, as for PbANKA (WT) only
combinations of β0 and RF could be determined (structural non-identifiability).
For PbmaLS_05(-) (KO), it was found that there is no reticulocyte preference, i.e.,
RF = 1. Numbers in brackets represent 95%-confidence intervals of estimates
obtained by the profile likelihood method if boundaries could be determined.
Parameter Unit PbANKA (WT) PbmaLS_05 (-) (KO)
Infection
rate, β0
×10−8 mz−1µl−1 h−1 (0, 4.84] 7.82 (7.36, 8.31)
Reticulocyte
Factor, RF
- [22.5, ∞) 1
Average In-
fectivity, β
×10−7 mz−1µl−1 h−1 1.13 (1.08, 1.16) 0.78 (0.74, 0.83)
but quite early into the infection also inhibits erythropoiesis [77–79]. A previous
study [78] that investigated this by observing expression levels of various genes
that are associated with erythropoiesis. Of relevance from this work is the finding
that genes known to show a strong association with erythropoiesis, namely α−
globin, β− globin major and β − 1− globin indeed show a change in their expres-
sion levels following malarial infection. This change with time can be modelled
using a logistic-loss function as represented in Eq. (3.11).




Here, λ defines the loss-rate of gene-expression or the loss of RBC production
and t0 the time point at which half of the maximal gene expression is reached.
On fitting such a model to the data from [78], we estimate λ = 2.22 d−1 (95% -
CI [1.31, 3.05]) and t0 = 3.70 d [3.28, 4.23] (see Table 3.2 and Figure 3.4). The
infection dynamics model is extended to include this malaria-induced erythropoi-
etic modulation hypothesis (i.e.. F0 in Eq. (3.4) is replaced by F0F (t)) and the
mentioned parameterization is used during all further analyses.
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FIGURE 3.4 A panel with results from the infection dynamics model that accounts for
disease-induced changes to erythropoiesis
(A). Fold change in expression levels of genes associated with erythropoiesis dur-
ing malaria infection. Symbols represent gene-expression levels of various genes.
Red solid line indicates best fit with parameter values described in Table 3.1 based
on 104 bootstrap replicates simulated from the distribution given by the gene ex-
pression levels at each time point (shaded area – 95% confidence interval). (B).
Dynamics of red blood cell concentration, reticulocyte proportion and parasitemia
for mice infected by either WT, n = 3 or KO, n = 6. The mean and standard de-
viation for each group are shown. Model results simultaneously predicting the
dynamics of all 3 measurements indicate a lower average infectivity for the WT
compared to KO. Shaded areas indicate 95%-confidence intervals. Corresponding
parameter estimates are shown in 3.2 (C). Obtained parameter combinations for
reticulocyte factor RF and infection rate β0 indicate a lower average infectivity
β per merozoite per hour for the KO parasite compared to the WT. KO parasites
have lower reticulocyte factors than the WT if similar infection rates β0 for both
parasites are assumed (red dashed lines).
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3.3.3 PbmaLS_05 (–) merozoites express a reduced infectivity
compared to PbANKAWT
The final infection model (see Equations (3.4)-(3.9)) encompasses the basic
erythropoiesis parameterization (see Table 3.1) and the extension that accounts for
erythropoietic modulation (see Eq. (3.11)). This final infection model is fitted to
the experimental data on total RBC count, reticulocyte proportion and parasitemia.
Extending the model to account for modulation of RBC production due to infec-
tion improves the prediction for the observed dynamics of reticulocyte proportion
thereby improving the overall model predictions for RBC count and parasitemia
too (Figure 3.4). The estimates of infectivity characterized by infection rate β0
and reticulocyte factor RF for each of the two parasite strains indicate that the
WT strain with an RF > 22 shows a more than 22-fold higher preference for
reticulocytes than normocytes (see Figure 3.4 and Table 3.2). In contrast to the
KO with RF = 1, meaning the KO prefers infecting reticulocytes and normo-
cytes equally as the model performs comparable to the model that assumes a pref-
erence for reticulocytes (RF ̸= 1) (AIC 40.7 vs. AIC 42.7). Despite that, the time
courses of the experiment are too short to identify definite reticulocyte preference
for the two parasite strains. A small value of RF is compensated by a high infec-
tion rate β0 and vice versa, because of which many combinations of β0 and RF
can fit the data equally well (Figure 3.4). Based on the estimates of combinations
of β0 and RF , the average infectivity, defined as the infection rate of a merozoite
in the erythropoietic system at the start of infection (see Section 3.2.3), is calcu-
lated for both the strains. Interestingly, the KO parasites have a lower average
infectivity as compared to WT parasites, thereby producing less potent infections
(β = 0.78[0.74, 0.83]×10−7 mz−1µl−1 h−1 for KO and β = 1.13[1.08, 1.16]×10−7
mz−1µl−1 h−1 for WT, numbers in brackets represent 95 %-confidence intervals;
Table 3.2). The slower increase in parasitemia for the KO strain (see Fig. 3.4)
can be attributed to a less infective KO strain, with its lower average infectivity.
If one assumes that infection rate β0 is unchanged between the two strains, the
resulting estimate for RF is consistently lower for KO than that for WT across
a wide range of β0 (Figure 3.4). Thus, our analysis concludes that KO parasites
may be less competent than WT parasites in productively infecting reticulocytes
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during the early erythrocytic stage of infection.
3.3.4 Testing other hypotheses
Though the central idea of this study is characterizing the KO strain with re-
spect to its infectivity and reticulocyte proportion, in this section it is examined if
differences in other infection parameters can justify the low parasitemia observed
during KO infection. It is well known that depending on the strain an infected
iRBC takes ∼ 24-72 h to complete, and between 8 and 32 merozoites are released
from every rupturing iRBC [74, 75, 80]. Therefore here it is assessed if matu-
ration time of an iRBC (tm) or number of merozoites released per iRBC burst
(m) for the KO strain are selected distinct to that of the WT strain can explain
the diminished parasite-load during early-stage KO infection in the blood. With
the infection model that accounts for reduced erythropoiesis, various values for
tm ∈ (10, 60) h and m ∈ (8, 36) were tested and the model estimates for para-
sitemia were compared to the data. The results show that if β0 and RF that are
identical for both WT and KO strains are assumed, the KO strain-iRBCs may take
a longer time to burst and produce merozoites as compared to the WT (tm = 36
h (KO) vs tm = 24 h (WT)). Such a delayed maturation of iRBCs would ensure
a slowly increasing parasitemia, eventually producing a lower parasite burden on
day 4 p.i. than the WT. On the other hand, any m ̸= 9 for the KO, keeping rest
of the infection parameters equal to the WT, could not lead to better parasitemia
estimates for the KO.
3.4 Discussion
InMalaria, the disease symptoms occur during the blood-stage of thePlasmod-
ium life cycle and this stage is a determinant of the resulting severity of disease.
Thus parasite replication and invasion of host target cells during the blood-stage
are crucial for designing novel therapeutics and malaria vaccines [67]. Within-
host mathematical models have been widely used to understand the Plasmod-
ium life-cycle and the host-parasite interaction at various scales for the same sys-
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FIGURE 3.5 Testing other hypotheses
(A). A longer iRBC maturation of tm = 36h for the KO as compared to tm= 24h
for the WT captures the dynamics of (B). reticulocyte proportion and parasitemia.
(C). No other value of merozoites produced from a single iRBC,m, can justify the
(D). observed difference in infection dynamics between the two strains.
tial differential equations similar to earlier models [12] is deployed to particularly
contradict target age-preferences displayed by two parasite strains, the PbANKA
(WT) and PbmaLS_05 (-) (KO). The age-preference was studied by comparing
preference to reticulocytes over normocytes during the early erythrocytic stage of
the parasite (upto 4 days p.i.) after infection via iRBCs. From this analysis I found
that Malaria hampers erythropoiesis and this phenomenon already contributes to
anemia during the early phase of blood-stage infection. The observed tremendous
decrease in reticulocyte proportion cannot be explained by a concurrent and very
slightly increasing parasitemia (see Figure 3.3). A reduction in erythropoiesis is
also reported for Plasmodium berghei at later erythrocytic stages in [19]. Other
factors includingmalaria-induced bystander deaths of uninfected RBCs [19,83,84]
may explain the loss of reticulocytes, but the phenomenon of bystander death can-
not explain the constant level of total RBC count (Figure 2.1) which hints at an
age-specific deterioration in the reticulocyte population. Therefore I extended the
mathematical model by [12] to account for altered erythropoietic dynamics dur-
ing malaria infection [78, 79]. This model was fit to the experimental data and I
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modelled the reduction in RBCsas a result of reduced production due to changed
erythropoietic conditions and loss of RBCs in an age-specific manner to infection.
The model confirmed that akin to previously observed [12,15–17,19] property of
some Plasmodium strains, the PbANKA strain preferentially infects reticulocytes.
A minimum 22-fold higher preference for reticulocytes compared to normocytes
in PbANKA parasites was estimated while considering the early blood-stage of
the parasite (Table 3.2). A maximal limit for the reticulocyte factor could not be
obtained (Table 3.2) as only combinations of RF and β0 could be ascertained that
lead to similar dynamics of parasitemia and reticulocyte proportion owing to the
structurally non-identifiable [85] parameters (Figure 3.4). Cromer et al. estimated
a value of RF ∼ 150 based on data from later stages of infection with Plasmod-
ium berghei [19]. If an RF is set to 150 (the estimate from [19]) in our model, the
model predicts that 65% of parasitemia is contributed by reticulocytes on day 4 p.i.
(Figure 3.6). This value is larger than the proportion of reticulocytes in the total
parasitemia observed on day 4 p.i. in rats infected with Plasmodium berghei [18]
(∼ 50%). However such a high value of reticulocyte factor is within the range of
RF estimated by our model. I also infer that different combinations of β0 and RF
can produce the same output for reticulocyte proportion and parasitemia, thereby
pressing the idea that combinations of β0 and RF should be considered while
comparing infection characteristics of two strains. Thus I calculate average infec-
tivity (β) and deduce that PbANKA parasites are more infectious as they have a
approximately 1.5-fold higher average infectivity than the parasites devoid of the
PbmaLS_05 gene (see Figure 3.4). I propose that it is for this reason that infection
due to KO strain develops poorly and leads to a lower peripheral parasite load of
KO than WT on day 4 p.i.. When I tested other hypotheses than target preference,
it was clear that a roughly 2-fold longer maturation time for iRBC infected by the
KO could provide an alternative explanation for the observed differing dynamics.
This supports the conclusion that deletion of PbmaLS_05 particularly leads to im-
paired parasite development and less successful infections in reticulocytes during
the initial blood-stage phase. Moreover, the small difference of 1.5-fold elevated
RF for the WT, though enough to explain the different dynamics of infection for
the two strains, is pessimistic, and the actual difference could even be larger than










































FIGURE 3.6 Comparison of the estimated infection parameters to results from another
study
(A) Development of infected normocytes and reticulocytes during infection with
WT parasites as predicted by the model using a reticulocyte factor of RF = 150
as estimated by [19]. The model predicts that 4 days after infection around 65% of
the infected red blood cells are reticulocytes. (B) Using the estimated parameter
combinations of the infection rate β0 and RF for PbANKA (Table 3.2), the model
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FIGURE 3.7 Distinguishing between the infectivity of WT and KO parasites as the in-
fection progresses through the blood-stage.
(A) The panels the combinations of the infection rate β0 and reticulocyte factorRF
that fit the data for WT (blue) and KO (green) parasites explaining the parasitemia
level observed. While infectivity characteristics for both parasite strains overlap
during early days post infection, the difference becomes prominent with infection
progression. (B) Zoom into a particular region of (A) to improve visual clarity.
fected mice showed signs of ECM, the analysis is restricted to early phase of the
infection, thereby affecting the precise identification of infection parameters due
to the following reasons: 1). parasite levels are too low and therefore prone to
measurement noise and 2). this model predicts that the difference in the strains
becomes more pronounced as the infection progresses 3.7. An analysis of long-
term dynamics of the two parasite strains is not possible as the WT infected mice
develop ECM on day 5 p.i.. Nevertheless, I explored the prediction of this model
over a duration of 20 days for the KO strain. This examination made a case for
changing infection dynamics after the initial phase of 4-5 days of blood-stage in-
fection (Fig. A.1). To summarize, our analysis in-spite of all the restrictions in
predicting a definite combination of the two parameters for WT as well as KO
strains, conclusively suggests that deletion of the gene PbmaLS_05 impairs the
infection potential of the parasite thereby causing the infection to not culminate in
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serious cerebral complication that is a precursor to ECM.
3.5 Conclusion
On the basis of the analysis via experimental data and mathematical model-
ing, it is clear that reduced RBC production is a hallmark of blood-stage Malaria,
and therefore should be accounted for in the infection model. Additionally, it is
inferred that the KO strain has a reduced average infectivity than WT, however it
remains to be ascertained if the KO has a lower reticulocyte factor RF or a lower
infection rate β0. One way to decouple the two hypotheses is to observe the infec-
tion dynamics of the two strains in the presence of abundant reticulocytes. Such an
experiment will shed more light on the target preference of the two strains. In the
following chapter, with data from one such experiment that involves pre-treating
the animals with Phenylhydrazine (PHZ) and a correspondingmathematical model
accounting for the pre-treatment is employed to understand the differing infection







It was concluded in the previous chapter that the deletion of PbmaLS_05 leads
to parasites that have impaired capability of infecting RBCs during the blood-stage
of Malaria as they show a lower average infectivity as compared to the WT strain.
In this chapter I take these findings ahead and determine whether the KO has the
same infection rate as theWT, but an impaired capability of infecting reticulocytes
or it has a lower infection rate, but a heightened preference to infect reticulocytes
than what is seen in the WT infections. In this study, experimental data from
animals that were treated with Phenylhydrazine (PHZ) to have abundant reticu-
locytes and infected with WT or KO iRBCs is used to model an infection model
under perturbed RBC age distribution. PHZ is known to induce artificial anemia,
also known as artificial reticulocytosis, thereby changing the age distribution of
circulating red blood cells (RBCs).
Some sentences and most of the figures of this chapter are reproduced from [56], which were
written together by Dr. Frederik Graw, Dr. Ann-Kristin Müller, Priyanka Fernandes and me. Many
sentences have also been taken from the supplemental material of [56], which were completely
written by me.
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4.1.1 Phenylhydrazine (PHZ) and its usage in inducing anemia
in mouse models
For many years, PHZ has been used for experimental induction of anemia in
animal models to study hemolytic anemia or anemia caused by destruction or re-
moval of the RBCs from the bloodstream [86]. PHZ causes peroxidation of RBC
lipids inducing hemolysis, i.e. the lysis of RBC, which leads to increased lev-
els of extracellular hemoglobin in the blood. Under homeostatic conditions, any
hemoglobin produced by hemolysis is reacted upon by certain compounds and is
scavenged by macrophages. However, during aggravated hemolysis, the process
of scavenging fails to keep up with the increased hemoglobin levels, which in turn
leads to a higher level of free heme [87,88]. The exact molecular mechanisms by
which PHZ induces destruction of RBC have not been fully elucidated, and a lot of
different processes have been proposed including biochemical modifications, such
as ATP decay and increased potassium permeability of cells [89]. It has been ob-
served that lysis is usually confined to mature red blood cells [90]. Reticulocytes
are not lysed although their hemoglobin level is affected [89]. Thus, a mathemati-
cal model describing the effects of PHZ treatment should consider age-dependent
effects of the treatment.
4.1.2 PHZ induced anemia and the resulting erythropoiesis
Anemia, be it non-hemolytic (for e.g. induced by bleeding) or hemolytic (for
e.g. induced due to a Plasmodium berghei infection) leads to enhanced erythro-
poiesis. In mice, the dominant site for erythropoiesis is the bone marrow. In addi-
tion, the spleen also acts as a minor erythropoietic organ. However, in situations
that deviate from normal homeostatic conditions, such as anemia due to bleeding
or hemolysis, the spleen becomes amajor site of erythropoiesis in order to compen-
sate for the excessive loss of RBCs as soon as possible [90,91]. Moreau et al. [88]
reported the presence of large numbers of erythroid BFU-E progenitors differenti-
ated from spleen precursors in mice under erythropoietic stress. As stated before,
treatment by PHZ causes hemolytic anemia and is characterized by the presence
of higher levels of free heme in the blood. It has been observed that this anemia re-
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sults in low hemoglobin levels (which is in positive correlation with the red blood
cell concentration, as shown in Fig. 1 from [92]), reticulocytosis (as a result of the
feedback) and splenic erythropoiesis [88]. Of importance here is that Moreau et
al. [88] also found a significant lower erythropoietic activity in the bone marrow
and a significant higher erythropoietic activity in the spleen during hemolytic ane-
mia as compared to non-hemolytic anemia. Their observations point towards an
additional source compartment for erythropoiesis besides the bone marrow when
modelling hemolytic anemia dynamics during PHZ treatment.
4.2 Aim of this chapter
This chapter aims at using the same approach as Chapter 3, of using math-
ematical modelling in combination with experimental data to compare infection
dynamics of WT and KO strain. However, the objective here is to modify the ex-
isting infection model to account for the existing anemic condition of the mice and
any long term effects that are caused by the treatment to the RBC age distribution
as well as characteristics of individual RBCs produced post treatment. This model
is used to further distinguish between the KO and WT infection dynamics.
4.3 Mathematical Model
Treatment with Phenylhydrazine (PHZ) is used for experimental induction of
anemia in animal models to study hemolytic anemia or anemia caused by destruc-
tion or removal of RBCs from the bloodstream [86]. Previous studies developed
mathematical models to determine and quantify the effect of PHZ on the RBC age
distribution and altered erythropoiesis [93]. However, these models were inad-
equate to describe the experimental data here, suggesting that they incompletely
addressed the effects of PHZ. To this end, several different known hypotheses for
the effect of PHZ on erythropoiesis were tested [86, 88, 93, 94] by fitting them to
the data of the PHZ-control group (Fig. 2.2).
Here, the effect of PHZ is modeled as an extension to the basic model describ-
























FIGURE 4.1 Schematic showing various hypotheses on the effect of PHZ treatment on
erythropoiesis
Chart showing the possible effects of PHZ treatment on red blood cells dynamics
categorized according to hemolysis (red) and stress-induced erythropoiesis (blue).
The different boxes indicate the unknown effects as they are tested within the mod-
els.
be considered to fall into three different categories namely (also see (Fig 4.1)):
1) PHZ induced hemolysis
2) stress induced erythropoiesis
3) altered RBC characteristics
Models incorporating different combinations of the various hypotheses describing
these effects (see Fig. 4.2) were constructed and tested in their ability to explain
the observed dynamics. In the following, five different representative models are
explained in detail.
Model A: This is the simplest of all models. The model assumes that the effect of
treatment is instantaneous by immediately lysing a fraction, ρ0, of RBCs (irrespec-
tive of their age) (see Fig 4.2 A). Erythropoiesis occurs according to the previously
determined conditions as described in Tab. 3.1, i.e., assuming no stress-induced
erythropoiesis.
Model B: As in model A, a direct lysis of a fraction, ρ0, of RBC upon administra-
tion of treatment, but a smaller fraction of reticulocytes γ, as compared to that of
normocytes is lysed [93] (Fig 4.2 B).
Model C: In addition to assumptions in model B, this model assumes that extreme
hemolysis as a result of the treatment leads to stress-induced erythropoiesis that
contributes to RBC production in addition to RBC production from the bone mar-
row. Thus, RBCs enter the blood stream from extra-medullary sites modeled with
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a constant influx of NP cells, after a time delay of TP since the time of treatment
(Fig. 4.2 C). A value of r close to 1 denotes that RBCs are produced in these or-
gans and a value of r close to 0 denotes that there is a repository of RBCs in these
organs ready to be circulated under stress.
Model D: In this model, the assumptions for hemolysis and stress erythropoiesis
are as in model C. Besides, this model assumes that the life span of RBCs that are
produced after treatment is reduced permanently by a factor η (Fig. 4.2 D) and that
this change in RBC characteristic is constant over the 5-day period post treatment
considered in our experiment.
Model E: Here, in addition to the previous model, it is assumed that the lifetime
of RBCs is assumed to recover over time. Meaning, immediately after treatment,
RBCs have a reduced lifetimewhichwill increase linearly to the generally assumed
lifespan of τRBC = 40 days over time. The parameter η′ denoting this increasing
life time linearly dependent on the time t.
4.4 Results
4.4.1 Exploring the data from PHZ experiment to determine
parasite dynamics under altered erythropoietic
conditions
The experimental data (in Fig. 2.2) also includes data from the naïve control
that were treated with 40mg/kg on two consecutive days. In these mice, a substan-
tial loss of red blood cell concentration to∼ 1/3 of the concentration under home-
ostatic conditions 2 days is observed after the last treatment with PHZ (2.5 × 106
cells/µl vs. 7.6 × 106 cells/µl, mean values; Figure 2.2). Likewise, corresponding
to the decrease in total RBC concentration, there is an increase in the proportion of
reticulocytes to upto 50%of the total RBC concentration at 5−6 days after the last
treatment (see Fig. 2.2). On the other hand, for WT or KO infected, PHZ treated
mice, substantial changes in RBC count and reticulocyte proportion are only visi-
ble on day 5 p.i.. The RBC count raising to 4.0±0.32 and 3.6±0.15×106 cells/µl




































































FIGURE 4.2 Sketches of different PHZ models considered
Sketch of the mathematical models including different effects of PHZ treatment
on erythropoiesis. Models are shown with increasing complexity from model (A)-
(E) distinguishing between reticulocytes R and normocytes N in the blood and
the bone marrow (BM) and extra-medullary sites (EM). All models and the cor-
responding parameters are explained in detail ahead. The standard parameters are
shown in Table 4.1.
control mice (see Fig. 4.4). The infected mice also show a smaller proportion
of reticulocytes as compared to naïve mice. However, within the infected mice,
the KO infected still have a ∼ 3 fold higher proportion of reticulocytes than the
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WT infected (42.6 ± 2.6% (naïve) 4.8 ± 1.2% (WT), 15.6 ± 1.0% (KO); Figs.
4.4). Within the infected groups, it is noteworthy that even though both the groups
possess similar parasitemia levels (22.5 ± 1.2% vs. 21.0 ± 2.0%), the proportion
of infected reticulocytes is higher for the WT than the KO (24.3 ± 4.6% (WT)
vs. 16.3 ± 0.8% (KO); Figure 4.4). With these measured values, the average
reticulocyte preference RP is calculated as the ratio of the proportion of infected
reticulocytes to proportion of infected normocytes. Given thesemeasurements, the
average reticulocyte preference RP, calculated by the proportion of infected retic-
ulocytes among reticulocytes divided by the proportion of infected normocytes in
total normocytes, resulting into RPW T = 1.46 and RPKO = 0.76. In agreement
with previous results in Fig. 3.4 (C), these observations suggest that deletion of
PbmaLS_05 potentially hampers the parasite’s ability to effectively infect reticu-
locytes.
4.4.2 Modelling the effects of PHZ on erythropoiesis and
predicting infection dynamics
Even today, a complete understanding of how PHZ leads to hemolysis and its
effects on the age distribution within the RBC population is still missing. Faster
aging of RBCs, direct lysis of RBCs and many other hypotheses have been pro-
posed. In fact, a number of these hypotheses are evaluated using mathematical
modelling in [93]. The suggested best fit model in [93] failed to explain the exper-
imental data here, mainly because of difference in experimental protocols between
the two studies. As a result, I developed many different models and considered the
best fitting model for further analysis. The various models were fitted to the naïve
control data from Figure 2.2. The results of the comparison are noted in Table
4.2. The parameter estimates for the top three best models are tabulated in Table
4.1. The data exhibit an increasing influx of reticulocytes on one hand, whereas
a decreasing net-loss in normocytes post second PHZ treatment on the other(Fig
4.4 (B),(C)). This considerable increase in the production of reticulocytes cannot
be accounted for solely by the anemia induced production from the bone marrow.
While comparing the various models for PHZ treatment shown in Fig 4.2, it was
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FIGURE 4.3 Output of the various models tested for the effect of treatment on erythro-
poiesis
Dynamics of RBC count and corresponding reticulocyte proportion after treatment
of C57/BL6 mice with two doses of 40 mg/kg of PHZ at day −2 and −1. The
mean and the standard deviation over n = 3 mice are shown. Lines indicate the
best fits of the models as shown in Figure . While model A and B are insufficient
in simultaneously explaining the dynamics of RBC concentration and reticulocyte
proportion after treatment, models C-E including stress-induced erythropoiesis by
extra-medullary sites significantly improve the fits. Model D and E provide the
best fits to the experimental data and are therefore considered in the subsequent
analyses. See Table 4.2 for a detailed overview on model performance.
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TABLE 4.1 Parameter estimates for models C-E
The values in brackets show the 95% confidence intervals based on profile likeli-
hoods
Model Parameter Unit Value
ρ0 0.524 (0.50, 0.54)
C
ρ 0.007 (0, 0.01)
Tp h 84.5 (83.2, 85.6)
Np ×104 cells µl−1 h−1 7.8 (7.5, 8)
r 0.97 (0.92, 0.99)
ρ0 0.38 (0.37, 0.39)
γ 0.006 (0, 0.04)
D
Tp h 82.8 (80.2, 84.1)
Np ×104 cells µl−1 h−1 7.7 (7.2, 8.1)
r 0.92 (0.90, 0.94)
η 4.18 (3.91, 4.46)
ρ0 0.35 (0.37, 0.39)
E
γ 0.006 (0.002, 0.01)
Tp h 83.3 (81.9, 86.1)
Np ×104 cells µl−1 h−1 7.3 (7.0, 7.9)
r 0.94 (0.89, 0.97)
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assume (i) instantaneous hemolysis with ∼ 35 to 50% of the RBC being lysed due
to PHZ administration, and (ii) stress-induced erythropoiesis with an additional
production of reticulocytes from sources other than the bone marrow. This addi-
tional production starts ∼ 4.5 days after the second PHZ-treatment has been given
(Fig. 4.3). Besides changes to the erythropoietic system, the model also suggests
that PHZ alters the characteristics of RBCs produced after the treatment. The treat-
ment reduces the average lifetime of RBC, τRBC ∼ 40 days to τRBC ∼ 8 days (see
Fig. 4.4 (C) and Table 4.1). The analysis also indicates that alongside a constant
death rate (model D), a linearly decreasing death rate (model E) is also a possible
explanation for the data (Tables 4.1 and 4.2, Figure 4.3. The infection model spec-
ified before (see Eq. ((3.4)- (3.9))) is extended to include PHZ treatment induced
effects (from the model D) to establish if the estimated infection parameters for
WT and KO previously are also applicable in the changed scenario. By combin-
ing the treatment model with the infection model, a mathematical framework that
emulates the experimental protocol in Figure 2.2.
TABLE 4.2 Model performance in explaining the naïve control data
The specific parameters that are estimated for each model, as well as the
AIC values indicating model performance are shown. The models with
the lowest AIC are selected. The AIC is defined as the residual sum of
squares divided by the residual degrees of freedom, which is the differ-
ence between the number of data points and the number of free parameters.
Model Parameters to be estimated AIC (RSS)
A ρ0 177.7 (10487)
B ρ0, γ 178.3 (10013)
C ρ0, γ, Tp, r, Np 72.9 (244)
D ρ0, γ, Tp, r, Np, η 19.9 (39)
E ρ0, γ, Tp, r, Np 19.4 (41)
dx1
dt





x1(t) − ρ1I(t = Tp)x1(t) (4.1)
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FIGURE 4.4 Conclusions from the PHZ treated and infected mice data
(A) Parasitemia (in % of RBC) above background was detected at day 5 post infec-
tion indicating equal levels between WT and KO-infected mice despite a roughly
3-fold higher reticulocyte proportion in KO- compared to WT-infected mice. The
percentage of infected reticulocytes was determined as well. (B) The measured
progression of normocytes and reticulocytes in PHZ-treated but uninfected ani-
mals (naïve) indicated an increasing net-influx of reticulocytes (blue line) and a












PHZ induced lysis 
γρ0
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FIGURE 4.5 Sketch of the mathematical model describing the main effects of PHZ treat-
ment on erythropoiesis
Themodel assumes that normocytes are lost to PHZ induced lysis (shown in green)
at a rate of ρ0, whereas reticulocytes are lost at a rate less than ρ0 by a factor
γ. Under such extreme loss of RBCs, in addition to RBCs produced in the bone










xi(t) − ρiI(t = Tp)xi(t), i = 2, . . . , n
(4.2)
ρi =





θk+(X(t−T ))k t ≤ tP + τP
F0
θk
θk+(X(t−T ))k + NP t > tP + τP
(4.4)
This combined model seen in Eqs. (4.1)- (4.4) is further analyzed to establish if
the estimated infection parameters for WT and KO previously are also applica-
ble in the changed scenario. I simulated the pre-treatment of mice with PHZ and
subsequent infection using different assumptions for parasite infectivity, β0, and
reticulocyte preference, RF . The predicted levels of parasitemia and reticulocyte
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FIGURE 4.6 Model simulations for different combinations of RF and β0
Predicted parasitemia and reticulocyte proportions after PHZ treatment on day 5
post infection for different combinations of reticulocyte factors, RF , and para-
site infectivity, β0. The heat-map in grey shows the relevant combinations for
WT (blue) and KO (green) leading to the average infectivity as determined during
untreated infection in the previous chapter. While for the KO-group relevant pa-
rameter combinations lead to matching reticulocyte proportions (∼ 13%) as in the
experimental data, combinations of RF and β0 for the WT-group predict reticulo-
cyte proportions roughly twice as high as seen in the data.
the KO strain by using the previously determined parameter combinations (Table
3.2), predicted reticulocyte proportions are ∼ 13%, comparable to the observed,
but predict a parasitemia of ∼ 1%. In contrast, the pre-estimated combinations
of β0 and RF for the WT strain predict a very high reticulocyte proportion, al-
most twice as high, as seen in the data and parasitemia that are only one-tenth of
the observed. Even directly estimating β0 and RF based on the observed para-
sitemia and reticulocyte proportion under PHZ treatment, the model predicts that
both groups have nearly all reticulocytes infected (80 ∼ 100%), which also does
not agree with the data (Figure 2.2). These results indicate that there is a complex
interplay between PHZ treatment and infection, and modeling them independent
to each other may lead to wrong predictions. The PHZ treatment model, developed
by fitting to the naïve control data does not suffice to predict disease dynamics for
PHZ treated animals.
4.5 Discussion
Phenylhydrazine was for the first time used in experiments in the year 1888
as a drug to induce hemolytic anemia in animals [95]. Since then it has been
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used regularly in various experiments to change RBC age distribution towards an
increased proportion of reticulocytes to normocytes. The transient effect of this
treatment, depending upon the dosage, provides an experimental setup to study the
effect of other processes (like Malaria infection dynamics) on the perturbed RBC
age distribution. In this Chapter, a two step approach was used to further elicit the
differences in WT and KO infection dynamics. In the first step, a PHZ treatment
model was developed by fitting the model to the naïve control PHZ treated data
and in the second step, the infection parameter estimates fromChapter 3 are used to
make predictions for WT and KO infection dynamics under the influence of PHZ.
In the first step, various models (from A-E) were tested, and the model D with the
least AIC was selected for the second step. In the next step, this model was used to
simulate infection dynamics for the two strains based on their respective infection
parameter estimates from the previous chapter. This combined model however
failed to explain the observed data, suggesting that effect of PHZ is altered under
the influence of Malaria infection.
On the basis of the analysis described in Chapter 3 that involved estimating
infection parameters for the WT and KO strains in untreated mice, it was found
that the KO strain exhibits a lower average infectivity than the PbANKAWT. This
difference in the magnitude of successful infections can be explained by two hy-
potheses. Either the KO parasites have a greater RF but lower infectivity β0 as
shown in Fig. 3.4 (C). This case would mean that the deletion of PbmaLS_05 re-
stricts the parasite’s infectivity to reticulocytes [96]. In mice pre-treated with PHZ
that leads to heightened reticulocyte production, such a reticulocyte restriction if
shown by the KO strain, would mean that the KO infects more reticulocytes as
compared to the WT, causing resulting reticulocyte proportion to be lower in mice
infected by KO than those infected by WT. On the contrary, the observed data
show 3-fold higher proportion of reticulocytes in KO- than WT-infected mice 5
days p.i. (Figure 4.4 (A)) As the levels of parasitemia and total RBC counts are
comparable, this indicates enhanced reticulocyte survival during infection with the
KO-parasite. Therefore, the analysis of the data from PHZ treated animals rather
suggests that deletion of PbmaLS_05 impairs the ability of the parasite to produc-
tively infect reticulocytes during the early infection phase. In the untreated case,
the estimated reticulocyte factor RF for the WT is around ∼ 1.4 times higher than
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the one estimated for the KOwhen assuming similar infection rates (Figure 3.4). In
addition to this, the calculated reticulocyte preference for KO-infected mice after
treatment with PHZ is roughly half the size of the one determined for WT-infected
mice. Reticulocytes are the preferential targets for most parasite strains [15, 16]
and the KO strain’s impaired ability to infect reticulocytes could explain the slower
development of parasitemia in the KO-infected mice than the WT-infected mice.
It turns out that several studies have implicated the need for parasites to infect
reticulocytes as a requisite for spreading infection. Metabolomic analysis of the
RBC has revealed that reticulocytes possess a higher content of carbon sources
and essential nutrients that make them preferred targets for WT parasites during
the early blood-stage [97]. Likewise, higher expression of CD47 on reticulocytes
was demonstrated to prevent phagocytosis and subsequent clearance of infected
cells by the host [98]. Therefore, it can be concluded that the major contributor
to the slower multiplication rates of the PbmaLS_05 (-) parasites is the parasite’s
inability to develop within reticulocytes. Beyond the blood-stage of infection, it is
also found that thePbmaLS_05 (-) infectedmice do not develop experimental cere-
bral malaria but only severe anemia [13], which corroborates previously proposed
correlation between severity of disease progression and cell preference [22, 99].
4.6 Conclusion
Comprehending changes to the erythropoietic system during Malaria infection
and PHZ treatment are critical in deciphering the effect of deleting maLS_05 on
parasite infection and reticulocyte invasion. In the analysis that focused on un-
treated animals, it was found that there are disease induced changes to the erythro-
poietic system during the blood-stage. Likewise, through the analysis of data from
treated animals infected with WT or KO strains, it was clear that a complex inter-
action of the treatment and ongoing infection, and considering them independent
of each other is not a valid assumption while modeling. Nevertheless, the infection
estimates from previous chapter and the experimental data from PHZ treated and
infected animals substantiate the claim that absence of maLS_05 indeed leads to
a poorly developing parasite, mainly because of the inability of such a parasite to
infect reticulocytes as efficiently as the WT. Given the suggested outcome of ab-
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sence of PbmaLS_05 on the productive infection of reticulocytes, the PbmaLS_05
(-) mutant parasite strain can serve as a tool to study the role of target preference
in disease progression and eventual onset or absence of cerebral Malaria. This
finding can further be explored in searching the factors that influence activation







Thus far I investigated how the malarial WT and KO strain compare in their
target cell preferences and infection rates during the blood-stage infection when
the mice were infected via the iRBC route. Despite concluding that the KO is a
weaker strain than theWTwhen comparing peripheral parasitemia and ECM caus-
ing capability, it is also important to make comparisons between the two during
the pre-pathalogical liver-stage. An analysis of these differences can lead to an
explanation for why the mice infected via KO sporozoites failed to contract ECM
even though they showed similar triggering of immune activation and immune
migration to the brain as the WT mice infected via sporozoites.
5.1.1 A silent, nutrient demanding stage before the onset of
disease symptoms
Plasmodium parasites cause malaria in vertebrate hosts. The Anopheles














FIGURE 5.1 Part of Plasmodium life-cycle within host liver and blood
The Plasmodium sporozoites enter the host liver cells. Inside the host cell, each
sporozoite undergoes division do form a schizont. The schizont matures further to
burst and release free merozoites that leave the liver and enter circulating blood.
Here the merozoites infect red blood cells, each of the infected red blood cells
mature and burst to release free merozoites that infect other uninfected red blood
cells.
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vary glands of the mosquito, parasites in the form of sporozoites are released into
the skin of the host. These sporozoites are motile and they traverse through blood
to reach the liver. Once inside the liver, the sporozoites start targeting hepato-
cytes. After a sporozoite settles down in a hepatocyte, a parasitophorus vacuole is
formed inside the host cell. This vacuole houses the sporozoite, where the parasite
develops further into the trophozoite stage or the feeding stage. The trophozoite
then gives way to schizont stage, the stage of multiple divisions. In fact, this rate
of division is one of the highest observed rate in eukaryotic cells [8]. This extreme
activity is matched by a tremendous increase in nutritional uptake by the parasite,
by scavenging nutrients and metabolites from the host cell cytoplasm, in addition
to its own metabolism [23,24]. Hepatocytes are highly active in protein turnover
and carbohydrate storage. Therefore hepatocytes represent a favorable environ-
ment for Plasmodium to thrive and replicate within the mammalian host [100].
During the terminal hours of the liver-stage, the infected hepatocytes burst to re-
lease the next stage of the parasite in the form of merosomes that are vacuoles con-
taining first generation merozoites [101]. Each schizont ends up producing tens of
thousands of merozoites that are released into the peripheral blood stream [102],
culminating the clinically dormant liver-stage.
5.1.2 Most promising target for vaccines
Under natural conditions, the number of productively infectious pre-
erythrocytic parasites is so low that the liver-stage is a bridge-head of infection
in the complex Plasmodium life-cycle [103, 104]. The strategy behind most po-
tential vaccines is to cause an arrested development in the liver so as to provide a
sufficient repertoire of antigens for the immune system to recognize but not caus-
ing any successful blood -stage infection [105]. These vaccines aim at inducing
protective immunity through mainly but not exclusively CD8+ T cells that are
important components of liver-stage immunity [106,107].
5.1.3 Autophagy and its relevance to liver-stage malaria
Autophagy, in general can be described as a regulated machinery that delivers
various components required for intra-cellular degradation (see Fig. 5.2). In re-
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FIGURE 5.2 Mechanism of Autophagy
The figure has been adapted from [111]. The cytoplasmic material to be degraded
is is delivered to the lysosomal compartment. The formation of an isolation mem-
brane is initiated by specific proteins. This isolation membrane elongates to en-
close cytoplasmic material including organelles and macromolecules. The mem-
brane matures to form an autophagosome. The outer autophagosome membrane
fuses with a lysosome, leading to the degradation of its contents. The degraded
contents including free nutrients are released into cytoplasm.
ality, in liver ’basal’ autophagy is fundamental in maintaining liver cell turnover.
Other than this, autophagy can be triggered due to two reasons. On the basis of
the type of reason triggering the autophagic pathway, autophagy can be selective
or canonical. Selective autophagy is initiated to devour intra- cellular pathogens
or specific damaged organelles, and is more targeted in nature. On the other hand,
canonical autophagy is stimulated by a nutrient sensing mechanism. Under con-
ditions of stress and starvation, nutritional dearth is compensated by activating
canonical autophagy, that causes bulk self-digestions of parts of cytoplasm and
cell organelles [24, 108].
Plasmodium schizonts thriving in the hepatocytes are targeted by selective au-
tophagy. The parasite vacuole membrane is laced by autophagic receptors by the
host, and is specifically targeted via the selective autophagy pathway [24]. It turns
out that some Plasmodium strains have also developed a mechanism to avoid this
by shedding off these receptors from the surface of their membrane [109]. The
others, that do not, end up scavenging on the remnants of the autophagic process,
and grow in size [26, 110]. Thus, not just nutrition but also the extent of selective
autophagy initiated by the host and the parasite’s defence against it becomes the
deciding factor in the level of parasite development in the liver.
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FIGURE 5.3 Experimental data for liver-stage development
HuH7 cells infected with 104 sporozoites of either WT or KO parasites were fixed,
24, 48, and 63h post-infection, respectively and stained with parasite-specific
markers to visualize the parasite by fluorescence microscopy. Images of para-
sites inside the liver cells at different time points post-invasion were recorded and
sizes of liver stages were measured. The data shown are pooled from two individ-
ual experiments for the sporozoite infection (n = 9 mice per group). The statistical
significance was determined using the Mann–Whitney U-test. Figure has been
reproduced and modified with permission from Priyanka Fernandes [13].
5.1.4 Aim of this chapter
While observing the development of the WT and the KO schizonts, it was ev-
ident that the difference between their growth is statistically insignificant. How-
ever, on careful consideration (see Fig. 5.3), the KO schizonts, look less developed
than theWT schizonts. The fact that one schizont produces merozoites in the order
of 104 suggests that observed small differences in the liver-stage could potentially
release significantly different population sizes of merozoites to set off the blood-
stage of infection. Thus, for the sake of completeness and towards achieving the
final aim of characterizing the infection pattern of KO, it is imperative, that com-
parisons between the two during the liver stage should be drawn. As the data from
WT and KO infected mice limit such comparisons, this chapter is speculative, and
aims at finding ways to overcome this limitation by proposing some hypotheses
and evaluating their plausibility:
1) Deletion of PbmaLS_05 gene may result in a parasite that is less efficient
in utilizing available nutrients.
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2) Deletion of PbmaLS_05 gene may result in a parasite that is less efficient
in escaping selective autophagy.
Using simple mathematical models to simulate the replication and growth of liver
parasites and the role of nutritional abundance, I do an analysis to establish how
probable the above two hypotheses are.
To design and parameterize the model, data from experiments that investigated
the influence of canonical autophagy on parasite establishment, growth and devel-
opment during the liver-stage of P. bergheiANKA in mice [26] has been used.
Prado et al. [26] found that autophagy in the form of selective autophagy is one
of the mechanisms that benefits the host in parasite clearance. On the contrary,
starvation-induced canonical autophagy in infected mice leads to better establish-
ment and growth of the parasite [26]. Thereby implying that nutrition availability
is of paramount importance for successful infections during this stage of parasite
life-cycle that is characterized by extremely fast nuclear replication rates. Here,
the data from these experiments is analysed with an objective to understand how
status of host nutrition and parasite nutrition uptake can lead to varying number
of infectious merozoites that become the carriers of infection for the blood-stage
after released from the liver. A proof-of-concept study is conducted to ascertain
if starvation positively impacts parasite development during the liver-stage by de-
veloping a mathematical model that best explains the data from [26]. Such a fitted
model will help in understanding how autophagy in general, may it be starvation-
induced canonical autophagy or infection-induced selective autophagy influences
parasite growth in the liver-stage. The results of this study are extrapolated to
hypothesize a possible reason for the reduced parasitemia exhibited by KO strain
lacking the PbmaLS_05 gene during the blood-stage of infection. This study aims
at designing future experiments so as to investigate that parasite lackingPbmaLS_-
05 either induces a low selective autophagic response in the host or has a reduced
nutrition uptake capability thereby leading to growth-arrested parasites.
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5.2 Mathematical models of parasite development
and dynamics of nutrition
5.2.1 Modeling parasite development during liver-stage
In this section, I present a simple ODE model to describe the events taking
place after sporozoites have successfully reached and infected hepatocytes. The
sporozoites settle into target hepatocytes as early as in minutes and to latest, within
2 h after reaching the liver [102]. Rest of the free sporozoites have been cleared.
The liver-stage infection in vivo is asynchronous, and all the different intra-hepatic
life forms have been observed to exist throughout the duration of liver-stage. How-
ever, to keep it simple, the model assumes that all potential infections have already
been established, and it will take atleast 48 h for any parasite inside the hepatocyte
to mature and burst the hepatocyte to release free merozoites. Thus, during the
time frame of interest, no new infections occur and the infected cells are only lost
either to host cells clearing the parasite. The parasites are cleared either by the
mechanism of selective autophagy or by the hepatocytes being recycled through
autophagy at the basal rate. Equation (5.1) illustrates the exponential decrease in







0 ; t ≤ τγγS ; t > τγ (5.2)
The extent of parasite multiplication during schizont stage is measured by the in-
crease in size of the parasitophorus vacuole. During the schizont stage, the size
of the parasitophorus vacuole increases rapidly in-order to house the parasite that
is undergoing division at a very fast rate. Equation (5.2) denotes the increasing
size S of the parasite vacuole at the rate of γ. I assume that after entering the host
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FIGURE 5.4 Parasite development and nutritional staus of the host
Interaction of parasite development and host nutritional status under (A). nutrient-
rich (or steady state) environment (B). nutrient-deficient (or starvation) environ-
ment.
replicating only after a delay of τγ . A sketch of such a basic model is presented in
Fig.5.4, (A).
5.2.2 Modeling starvation-induced liver autophagy and the
changing nutrition levels
Nutrient deprivation triggers liver autophagy. This canonical autophagy is re-
sponsible for metabolic compensation; a term for recycling sugars, fatty acids and
amino acids that are products of autophagic breakdown of cytoplasmic compo-
nents [108]. It was found that mice deficient of Atg5 could not live through se-
vere neo-natal starvation, and died within 24 h after birth [112]. Therefore, liver
autophagy is an important survival machinery in maintaining energy homeosta-
sis [112].
In their quest to know themechanism of autophagy-dependent release of gluco-
genic amino acids for glucose production, Ezaki et al conducted experiments on
starved naive and starved, Atg7 deficient mice. They observed that the begin-
ning of canonical autophagy in mouse-liver coincided with the drop in blood in-
sulin levels, starvation-induced autophagic proteolysis occurred in the liver and
that the released amino acids are converted to glucose to maintain blood glucose
levels [108]. Here, I model the fluctuations in free amino acid levels in the en-
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vironment surrounding a hepatocyte using the free-amino acids measurements in
liver tissue as presented in [108]. It is evident from these data that the level of in-
sulin in blood drops at 18 ∼ 24 h, which is sensed by the liver. The concentrations
of the 9 amino-acids measured in the liver tissue reach maximum after 24 hours
of starvation. After this peak, the concentrations start declining, and reach normal
levels after 36 hours of starvation. Ezaki et al also observe that the concentrations















(t − τ3) + NSS ; τ2 < t ≤ τ3
Nss ; τ3 < t < ∞
(5.3)
I interpolated this data and formulated a mathematical representation N(t) for
perturbations in free amino acids concentration as a piecewise function of the du-
ration of starvation (see Eq. (5.3)). NSS stands for amino acid concentration at
steady state and Nmax for the maximum amino acid concentration attained during
starvation. The parameter τ1 is the time at which the nutrient concentration begins
to rise above the steady state, τ2 is the time at which the nutrient concentration is
at its peak, τ3 is the time taken for the concentrations to go back to steady state in
spite of continued starvation.
5.2.3 Modelling the effect of starvation on parasite
development
The models described in Eq. (5.1), Eq. (5.2) and the effects of starvation
N(t) on nutrition (Eq. (5.3)) are combined to mathematically depict the interplay
between parasite development in liver and starvation-induced autophagy. Under
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the assumption that incidence of canonical autophagy, which leads to excessive
availability of free nutrition in the liver tissue, benefits the nutrient demanding
shizont stage replication, eventually causing more parasites surviving this stage.
In Eqs. (5.4) and (5.5), F (t) is nothing but the function N(t) parametrized to
emulate specific starvation durations as per the experimental protocol in [26] (see
Chapter 2 Subsection 2.2.2). The loss rate δ in Eq. (5.1) is compensated by the
rate δAF (t) in Eq. (5.4).
dI
dt
= −(δ − δAF (t))I (5.4)
Next, I hypothesize that parasite replication is accelerated and the surviving
parasites thrive because of newly available autophagy released free nutrients. The
rate of replication γ in Eq. (5.2) is increased by a factor γAF (t) in Eq. (5.5),
whereas the delay τγ is the time duration after which the parasite starts growing
inside the hepatocyte. A comparison of the changed circumstances under starva-




0 ; t ≤ τγ(γ + γAF (t)) ; t > τγ (5.5)
5.3 Results
To determine the effect of host nutritional status on parasite survival, in the
first attempt I used the combined model in Eq. (5.4), with nutrition fluctuations
modeled on the lines of Eq. (5.3). A better approach to fit the data would be
to first establish the baseline rate of loss of infected cells and in the second step,
extend the baseline model to include effects due to starvation. This approach could
not be taken here, precisely because of the lack of appropriate data. Liver- stage
malaria parasite is notorious for its very low parasitemia in the liver [48, 113],
thereby impeding an analysis in vivo. The data available around absolute numbers
of infections established in the liver are through in vitro experiments [100] and
[26]. A drawback of using cell lines (like Hepa1-6 used in [100] ) for in vitro


















































FIGURE 5.5 Fold change in nutrient concentration with respect to duration of starvation
(A). Fluctuations in nutrient concentration modelled on the lines of data from
[108]. (B). Fluctuations in nutrient concentration modelled as a smooth S-curve.
they were derived from and therefore may not be representative of the infection
dynamics occuring in vivo [48]. Moreover, sporozoite infectivity is also affected,
and therefore the percentage of parasitized cells obtained in in vitro infections is
relatively low. In summary, using data from an in vitro experiment to predict data
from in vivo experiments would lead to a gross error.
5.3.1 Abrupt changes in free nutrition do not fit the observed
parasite growths under different levels of starvation
The model was fitted to the observed differences in parasites that are alive
at 40 hpi between various starvation conditions in vivo. The data is described
in Chapter 2, Subsection 2.2.2 and Fig. 2.4. Once the sporozoites successfully
enter the hepatocytes and start maturing inside them, the total number of infected
hepatocytes only decreases with time. The number of infected hepatocytes reaches
its maximum within 2 hours of the sporozoites reaching the liver. Assuming the
maximum number of infections as 1, the model tracks the decline in the infected










(t − τR) + NSS ; τS < t ≤ τR
Nss ; τR < t < ∞
(5.6)
Under starvation, the decline in the population of infected cells is slowed by a
factor of F (t)δA. As it is known from [114] and [115] that the maximum increase
in the release of free nutrients via autophagy under starvation is two to three fold
of the normal rate. Therefore, assuming the basal release of free nutrients to be
at 1 under nutrient - rich conditions, the function F (t) is parametrised such that
F (t) ∼ (1, 3) (see Fig.5.5 (A)).
0 <δ < 1 (5.7)
0 ≤δA ≤ max(F (t))δ (5.8)
Amodel denoted asM1 comprises of Eq. (5.4) and nutrition fluctutationsmod-
eled using Eq. (5.3) to predict the changing parasite numbers over time I during
the liver-stage and Eq. (5.5) with nutrition fluctutations modeled using Eq. (5.3)
to predict the changing parasite size over time S during the liver-stage. The model
M1 is fitted to the data from [26] with the objective of estimating five parameters.
Two of these parameters, δ and δA are obtained by fitting the model to the data in
Chapter 2, Fig. 2.4 A. As stated earlier, it is expected that the parasite number only
decreases with time, in both nutrient-rich or nutrient-scarce situations. Therefore
it is only logical to constrain the counter parameter δA as in Eq. (5.8).
The resulting estimates are reported in Table 5.1 (see Model M1). The esti-
mated value of δ is very high leaving as little as 0.002% of parasites alive at 40
hpi (Fig.5.6 A, Model M1). Moreover, the model underestimates the proportion
of alive parasites in 24 h of starved hosts compared to that in control hosts and
predicts no difference between 36 h starved and 36 h pre-starved hosts, at 40 hpi.
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On fitting the model M1 to predict the parasite size data in Chapter 2, Fig. 2.4 B
to estimate the remaining three parameters, namely γ , γA and τγ , it was observed
that the model M1 fails in predicting the difference in ratios of parasite sizes at 40
hpi in starved animals to control animals (see Fig. 5.7 C).
In the 36 h pre-starved group, at the time of infection, the mice have been
starving for a duration of 12 h. A prolonged 12 h starvation may weaken the host,
thereby affecting its immune response. Hence, there is a high chance of more suc-
cessful infections taking place in this group of mice than the other starved groups
that began their starvation period only after the intravenous sporozoite infections.
Assuming a 1.2-fold higher initial number of infected hepatocytes for the pre-
starved group, model M2 is introduced. This model is fitted to the data and the
five parameters (same as model M1) are estimated again. Using model M2 though
improves the prediction of the parasite number in the pre-starved group (see (5.6)
B, modelM2), it does not improve the prediction of parasite number in 24 h starved
group (see (5.7) B, model M2). In addition to this, both the model M1 andM2 pre-
dict a lower parasite size for the pre-starved group than 1). predictions of the 36
h starved group as well as 2) observed parasite number for 36 h pre-starved group
(see Fig. (5.7) C). Thus, in general, both the models M1 and M2 (as a modified
M1) fail to capture most of the characteristics of the data (see Fig. (5.6) D, model
M1 and M2).
5.3.2 Gradual and persistent changes in free nutrition fit the
observed parasite growths
In the models M1 and M2, the fluctuations in concentration of amino acids
started late (around 18 h), reached a peak quickly (within 6 h; i.e. at 24 h of star-
vation), dropped to the normal concentration in a short span (within 12 h; i.e. at 36
h of starvation) and refeeding immediately brought down the concentration levels
to normal (within 20 mins). The evidence for such dramatic changes in amino
acids concentrations were observed by Ezaki et al. (in [108]) at the tissue level.
One may argue that the nutritional status in the liver tissue or surroundings of a
hepatocyte may be different than the status quo inside the hepatocyte. The cells
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FIGURE 5.6 Comparison of number of parasites predicted by various liver-stage models
Model estimates of parasite numbers for Control, 24h starved, 36h starved, and
36h pre-starved for (A) Model M1, that assumes abrupt changes in free nutrition
as proposed in [108], (B) Model M2, same as M1, except assuming more initial
numbers of parasites in the pre-starved case, (C) Model M3, with nutrient con-
centrations following an S-curve. (D) Comparison of all model outputs with error
bars showing 95 % confidence bounds based on profile likelihoods alongwith the
data showing parasite numbers at 40 hpi, the parasite numbers at 40 hpi for the
control group are considered to be 100%.
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TABLE 5.1 Parameter estimates for different models
Parameter estimates with 95% confidence intervals (based on profile likelihoods)
for model M1 and M2
Model Parameter Unit Value
M1
δ h−1 2.7[1.8, 4.0] × 10−1
δA h
−1 1.8[1.5, 2.0] × 10−1
γ h−1 1.0[0.7, 4.0] × 10−3
γA h
−1 3.0[0.9, 8.0] × 10−2
τγ h 17.5[15.2, 18.5]
M2
δ h−1 2.8[1.8, 4] × 10−1
δA h
−1 1.7[1.5, 2.0] × 10−1
γ h−1 1.0[0.7, 4.0] × 10−3
γA h
−1 3.0[0.9, 8.0] × 10−2
τγ h 17.5[15.2, 18.5]
tionally, there may be a lag between the concentrations varying at the tissue level
and those varying at the cell level if one accounts for the time taken for nutrition
transport into an individual cell from the extracellular space. This lead to replac-
ing of the piecewise function N(t) described in Eq. (5.3) by a logistic function
Ñ(t) (see Eq. (5.9)). Here a third model M3 is introduced, which comprises of
the exponential loss in alive parasites (see Eq. (5.4)), the dynamics of parasite size
(see Eq. (5.5)) and function Ñ(t) from Eq. (5.9). In Eq. (5.9), Ñss stands for the
amino acid concentration at steady-state or nutrient-rich situation, Ñmax for the
maximum amino acid concentration attainable and τS is the starvation time dura-
tion. k and τ0 are parameters of a standard logistic function. For the time during
which animals are starved (i.e. t ≤ τS), Ñ(t) is a logistic curve, whereas for time
after refeeding (i.e. τS < t < ∞), Ñ(t) is an inverted logistic curve. The model
assumes that the increase and decline of the nutrient concentration are symmetrical
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about t = τS (see Fig.5.5 B).
Ñ(t) =

Ñss ; ∀t under nutrient rich conditions
Ñmax − Ñss
1 + e−k(t−τ0)
+ Ñss ; t ≤ τS
Ñmax − Ñss
1 + e−k(2τS−t−τ0)
+ Ñss ; τS < t < ∞
(5.9)
This model was then fitted to the data as the previous models, the estimates of
various parameters are listed in the Table 5.2. With this model, there is a sizable
population 6 % of parasites surviving upto 40 hpi (see Fig.5.6 C, Model M3). Not
only that, the premise of gradual and sustained transitions of nutrient concentra-
tions results in difference in the parasites surviving under 36 h starvation and 36
h pre-starvation (see Fig.5.6 D, Model M3). With an AICC = 0.33 (vs AICC =
20 for model M2), model M3 performs better than M2 in predicting the parasite
numbers and parasite size under various starvation conditions.
TABLE 5.2 Parameter estimates for model M3
Parameter estimates with 95% confidence intervals (based on profile likelihoods)
Model Parameter Unit Value
M3
δ h−1 7[1, 10] × 10−2
δA h
−1 2[1.9, 2.8] × 10−2
γ h−1 1.1[0.3, 3.8] × 10−1
γA h
−1 3[1, 8] × 10−3
τγ h 17.5[15.2, 19]
k − 0.3[0.1, 0.5]
τ0 h 12.3[10, 18]
5.4 Discussion
In this chapter, I aimed at finding a qualitative relationship between parasite
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FIGURE 5.7 Comparison of size of parasites predicted by various liver-stage models
Model estimates of parasite size for Control, 24h starved, 36h starved, and 36h
pre-starved for (A). Model M1, that assumes abrupt changes in free nutrition as
proposed in [108], (B). Model M3, with nutrient concentrations following an S-
curve. (C). Comparison of all model estimates with data showing parasite size at
40 hpi, with error bars showing 95 % confidence bounds (based on profile likeli-
hoods) on the model output. The parasite size at 40 hpi for the control group are
considered to be 100%.
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low number of parasites left at 40 hpi, and predicted no difference in the parasite
numbers at 40 hpi between 36 h starvation and 36 h pre-starvation groups (see
Fig. 5.6 A and D). The second model M2 was then introduced to check if higher
initial numbers of parasites in the pre-starved case, could improve the model fits.
Though this change in the model lead to a better prediction of the pre-starved case,
the parasite numbers were still underestimated for the 24 h starved group (see Fig.
5.6 B and D). Even in estimating the parasite size, both the models M1 and M2
(which had identical equations for the change in parasite size with time) performed
poorly (see Fig.5.7 A and C). This time, the 36 h pre-starved group was estimated
to have parasite size smaller than that of 36 h starved group which contradicts the
observations made in [26] (see Chapter 2, Subsection 2.2.2, Fig 2.4). The model
M3, with a logistic relationship between the starvation time and concentration of
free nutrition lead to better fits for the parasite growth that included the measured
alive parasite numbers and size of the parasite.
The liver-stage ofPlasmodium lasts for∼ 52 h in rodents [113]. During the late
phase of this stage, the infected hepatocytes burst to release merozoites contained
in the merosomes. The average parasite fitness at the end of the liver-stage is a
pre-cursor to the extent of blood-stage infection. The liver-egressed merozoites
pass the lung and infect RBCs. Here a new term, average parasite fitness P (t) is
defined which is the average number of merozoites relative to the control released
at time t from the liver to carry on the blood-stage infection. As discussed earlier,
the size is directly proportional to the number of divisions undergone inside the
parasitophorus vacuole to produce merozoites. Therefore P (t) is calculated as a
product of the number of alive parasites and the mean size of a parasite at a given
time. Using the model M3 to predict I (see Eq. (5.4)) and S (see Eq. (5.5)) over
time, the average parasite fitness P is calculated over time. From the predictions,
it is clear that most number of merozoites will be released from the liver during
the 36 h pre-starved case, followed by the 36 h starved mice, and then by the 24 h
starved mice. This clearly indicates that a starved host is beneficial for the liver-
stage parasite. Even though the gain in parasite size is only ∼ 1.2-fold (see Fig
5.7) in the most extreme starvation case (36 h pre-starved), due to the dual effect of
gaining in parasite numbers (∼ 5.8-fold, see Fig 5.6) and parasite size (∼ 1.2), the
































FIGURE 5.8 Parasite fitness P (t) as predicted for the three starvation groups relative to
control.
The fitness of the parasite increase with the extent of starvation of the host. For a
host that is 36h starved, with 12h pre-infection and 24h post-infection, the
product of total parasite parasite number and mean size of the parasite is
approximately 10 times than for the parasites that infect a normally fed mouse.
(∼ 10 see Fig. 5.8). Assuming that under controlled conditions ∼ 103 merozoites
are released per infected hepatocyte that bursts, at the culmination of liver-stage,
∼ 104 merozoites will be released in a host that was 36 h pre-starved . In addition
it is also evident from the analysis that under nutrient-rich environment (from the
point of view of the parasite), the liver-stage Plasmodium certainly prefers to keep
more parasite infected hepatocytes alive, rather than higher multiplication inside
each infected hepatocyte. Even though extreme starvation of the host is beneficial
for the parasite, there exists a trade-off. Starving host would lead to better thriving
parasites, but an extremely starved host may succumb to starvation, leading to a
defeated parasite.
Intracellular pathogens like Plasmodium depend completely on the host ma-
chinery for nutrients. For these pathogens, nutrients act as source of energy, reg-
ulators of various functions including metabolism and growth [116]. Mancio et
al observed that Plasmodium blood-stage parasites adjust their multiplication rate
corresponding to host dietary calorie changes [116]. It was found that peripheral
parasitemia was significantly lower in calorie restricted hosts than supplemented
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hosts in the erythrocytic stage. In addition, the experimenters were also able to
change severe disease systems in calorie restricted hosts, as such animals did not
develop experimental cerebral malaria in contrast to their supplemented counter-
parts [116]. These results are contrary to what has been observed during the liver-
stage in [26,27,100], where nutrition restriction or starvation of the hosts leads to
better thriving parasites. The liver and blood stages of Malaria are good examples
of the two kinds of relationship that exist between host nutritional environment and
parasite fitness [117]. In the liver-stage, the host environment is negatively cor-
related with parasite environment [26, 27, 100], whereas in the blood-stage, there
exist a positive correlation between the two factors [116].
Here, by developing an adequate mathematical model that predicts the data
measured by [26], it has been established that parasite growth during the liver-
stage absolutely depends on the balancing act of autophagy, that on one hand se-
lectively eliminates the parasite and on the other hand enhances growth of the par-
asites by releasing excess nutrients in the process of cellular degradation. In [26],
starvation was used as a tool to highlight the role of autophagy in the liver in nur-
turing healthier parasites that eventually lead to increased parasite load at the end
of the liver-stage. During starvation-induced canonical autophagy, liver acts as
a source of nutrition for various organs. Thus, in case of liver-stage malarial in-
fection, the usual host-parasite relationship of starved host leading to underdevel-
oped parasite is reversed, and Plasmodium ends up developing even better while
infecting a starved host. These experimental observations and a qualitative proof
of the hypothesis that autophagy promotes parasite growth in the liver does not
only highlight the role of autophagy but also emphasize that abundance of nutri-
tion for the parasite gives impetus to parasite growth. Therefore, site of infection,
host nutritional status and the current stage of parasite life-cycle are important fac-
tors governing the interplay of host nutrition and parasite survival and growth. In
summary, studies analyzing both the stages, liver-stage ( [26], [100] and [27]),
blood-stage ( [116]) directly imply that nutrition availability in the environment
and the parasite’s capability of taking up these nutrients are important factors in
parasite establishment in the host, the resulting parasitemia and severity of disease
in Malaria.
Fernandes et al. in [13] observed that the gene PbmaLS_05 (that was deleted
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to produce the KO strain) localizes to the apicoplast during liver and blood sch-
izont stages. A cell organell, apicoplast is a unique biological feature of Plas-
modium and other apicomplexan parasites [118]. The functions of the apicoplast
range from well characterized fatty acid synthesis, isoprenoid precursor synthesis
and housekeeping to so far poorly characterized import and export of metabolites,
production of energy and reducing power and the growth and division of the or-
ganelle [119]. The apicomplexan parasites have a complex life-cycle that spans
more than one host and more than one organ inside the host. The apicoplast capac-
ities are essential only to parts of parasite life cycle, and differ amongst the parasite
species. For example, apicoplast fatty acid biosynthesis is essential to Toxoplasma
parasite (another apicomplexan) living in mice. However, in the case of Plasmod-
ium in mice, apicoplast fatty acid biosynthesis is redundant in the blood-stage, but
crucial in the liver-stage [120].
In this chapter, a proof-of-concept study to check the positive correlation be-
tween host starvation and parasite fitness during the liver-stage was done that high-
lighted the importance of nutrition availability and nutrition uptake capability of
the parasite during liver-stage in disease progression. This qualitative understand-
ing along-with the so far discovered functions of the apicoplast and the observa-
tions made by [13], the following two hypotheses can be put forward.
1) PbmaLS_05 may have a role to play in the exchange of metabolites across
the PVM and host cell cytoplasm. The reason for KO under-developing
in the late liver stage, could be its inability in capturing and/or utilizing as
many nutrients as the WT, and therefore leading to less number of mero-
zoites being released from the liver to the blood at culmination of the liver-
stage and commencement of the blood-stage. A study found that an enzyme
Acetyl-CoA carboxylase (ACC), expressed in the apicoplast, is required for
host biotin metabolism during liver-stage development and has no function
during the blood-stage [121]. This points at the role of apicoplast in syn-
thesizing nutrients during the liver-stage and a probable direct link between
host nutritional status and parasite growth. Thus, in our case, PbmaLS_05
could be implicated as not a necessary but a beneficial participant in parasite
nutrition uptake and utilization.
2) The gene PbmaLS_05may have a role to play in the stimulation of selective
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autophagy. The KO strain may be better at hiding from the initial response
of the host-liver, the so-called selective autophagy. As a result of which,
less parasites may be eliminated in the liver-stage than in the case of WT
infection. However the parasites that survive, may be underdeveloped ow-
ing to nutrient constraint that could have been elevated, had the parasite
induced selective autophagy that would have been instrumental in produc-
ing nutrients as a by product. In this scenario too, the underdeveloped KO
schizonts would end up producing less number of merozoites as compared
to the WT, thereby leading to a disadvantage for the parasite at the start of
the blood-stage.
The future experiments could focus on analyzing the potential role of PbmaLS_05
from this perspective.
5.5 Future work
In a bid to clearly establish if deletion of PbmaLS_05 diminishes the parasite’s
nutrition uptake and/or utilization ability, further investigation is required and in
this section I suggest an experimental protocol on the lines of [26] and [13] for
this. Two groups of C57BL/6 mice divided into a control group, or groups fasted
for 24 h or 36 h or 36 h pre- straved (12 h prior to infection and 18 hpi) to be in-
fected with 2×105 WT or KO sporozoites. For all mice, livers are to be harvested
at 40 hpi for histology analyses to record the total number of parasites alive and
average size of the parasite inside the hepatocytes. The mice starved for various
duration would ensure a magnification of the difference between WT and KO par-
asite development (if any). As a precaution, it should be ensured that the mice in
the starvation groups are ’starve-synced’ meaning that care must be taken that the
mice have a similar nutritional status before start of the experiment as explained
in [48]. Such an experiment will disentangle the difference in WT and KO par-
asites during the liver-stage of infection. If it is concluded from this experiment
that there is no significant difference in the WT and KO strains during their life-
cycle in developing from sporozoites to merozoites, our main speculation that the
two strains differ only during the blood-stage of infection will be cemented even
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more. On the other hand, if it is concluded, that the KO differ significantly dur-
ing the liver-stage, further investigation would be needed to find if the KO strain
triggers a weaker selective-autophagic response in the host as compared to the
WT. After quantifying the difference in the parasite load during the liver-stage
for both the strains and the blood-stage infection for the two strains with differ-
ent initial number of free merozoites that have egressed the liver ready to infect
RBCs in circulation should be looked at. Another interesting aspect to investigate
will be to ensure if Plasmodium also manipulates to induce host cell autophagy
to enhance its capture of host nutrients as the other apicocomplexan parasite Tox-
oplasma gondii [122], [123]. Based on these experiments and more information
on Plasmodium parasite’s intake inside the hepatocyte, the model presented here
should be enhanced to represent a more real picture of the relation between host







WT and KO infections
6.1 Introduction
Cerebral Malaria (CM) is one of the leading causes of severe Malaria and
thereby Malaria-associated deaths. In the year 2016, out of the recorded 216 mil-
lion cases ofmalaria, 445,000 cases culminated in death [1],∼ 13% of these deaths
were due to CM [30]. At present, when Plasmodium has started to develop anti-
malarial drug resistance [32] and the low efficacy of the RTS,S vaccine, devel-
opment of drugs that attack specific pathophysiological events is most important.
Imbalance of pro- and anti-inflammatory [124], microvascular obstruction by par-
asitized RBCs (pRBCs) [125], immune activation of endothelial cells and their
dysregulation [126] and breakage of blood-brain barrier [127] have been reported
to be involved in the pathophysiology of CM. However, the processes that cause
these changes and how these changes are coupled to give rise to cerebral symptoms
during Malaria are still unidentified to a large extent. Understanding these process
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could become the basis for adjuvant therapies and finding of new biomarkers for
diagnostic of disease progression [33].
The jury is still out on the primary cause of CM. There are two prominent
schools of thought about ascertaining the main reason behind coma and CM [128]:
1) School of sequestration: The level of pRBC sequestration and vascular con-
gestion correlates with disease severity; pRBCs with impaired cytoadher-
ence causes protection against CM [129]; and adjuvant therapies based on
cytokine activation are not effective [130].
2) School of cytokines: Plasmodium vivax does not cause pRBC sequestration,
however it causes endothelial activation and CM [131]; Pro-inflammatory
TNF correlates with disease severity and is the main cytokine involved in
CM [132].
The research on CM so far is not conclusive in finding the primary factor that leads
to the development of CM, one of the above two hypotheses may be true or it may
also be a combination of the two.
6.2 Aim of the chapter
In this chapter, I focus on differentiating the severity of disease development
between the WT and KO strains. An experiment was carried out to measure fea-
tures that are considered to be signatures of immune activation in the brain and
the spleen of mice (see subsection 2.2.3). Here, by considering individual mouse
behaviour and using model-based machine learning technique, I find a subset of
salient features from the measured features that are sufficient to distinguish ECM
mice from the non-ECM mice, irrespective of the route of infection (via intra-
venous injection of sporozoites or injection of iRBCs). From this analysis I thereby




The data recorded in the experiment described in Subsection 2.2.3 form the
features, predictors or covariates; hereby referred to as features for the learning
algorithm. The feature matrix is represented a X in which each column represents
a measured variable (m = 16) and each row represents the measurements from a
particular mouse (n = 60). A dependant variable named “disease”, denoted by
a vector Y , is added to this dataset. The entries of Y , also known as the class
variable, are filled with a class ‘1’ if the mouse was observed to have developed
ECM and with a class ‘0’ if the mouse did not develop any cerebral symptoms.
X =















6.3.2 Feature selection using correlation analysis
On the basis of the hypothesis [133] that a good feature subset is one that con-
tains features highly correlated with the class yet uncorrelated with each other, a
correlation analysis is done on the feature set. In the first step, Pearson correlation
coefficient (PCC) is calculated for each of the feature paired with the dependant
variable ”disease” to find which features are highly correlated to the dependant
or class variable. Only features that have |PCC| ≥ 0.4 are considered in the next
step of feature selection. In the second step, a feature set is chosen such that it
contains features that are uncorrelated to each other. As the feature NIFNB has the
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TABLE 6.1 All the features in the dataset and their meaning.
Feature name Description
NCD4B Number of CD4+ T cells isolated from the brain
NCD4S Number of CD4+ T cells isolated from the spleen
NCD8B Number of CD8+ T cells isolated from the brain
NCD8S Number of CD8+ T cells isolated from the spleen
NLYMB Number of lymphocytes isolated from the brain
NLYMS Number of lymphocytes isolated from the spleen
NIFNB Number of Pb1-specific IFN-γ+ CD8+ T cells in brain
NIFNS Number of Pb1-specific IFN-γ+ CD8+ T cells in spleen
PCD4B Proportion (%) of CD4+ T in lymphocytes isolated from the brain
PCD4S Proportion (%) of CD4+ T in lymphocytes isolated from the spleen
PCD8B Proportion (%) of CD8+ T in lymphocytes isolated from the brain
PCD8S Proportion (%) of CD8+ T in lymphocytes isolated from the spleen
PLYMB Proportion (%) of lymphocytes in WBCs isolated from the brain
PLYMS Proportion (%) of lymphocytes in WBCs isolated from the spleen
PIFNB Proportion (%) of Pb1-specific IFN-γ+ CD8+ T cells in brain
PIFNS Proportion (%) of Pb1-specific IFN-γ+ CD8+ T cells in spleen
highest PCC in Table 6.2, we assume that this feature is most likely to be a rel-
evant feature in predicting the output class variable. Keeping this in the feature
set, other features are added one by one to the final set ensuring that they have
|PCC| ≤ 0.7. Following this criterion, we do not add the features PIFNB (PCC = 0.8
with NIFNB ), PIFNS (PCC = 0.72 with NIFNB ), PCD8B (PCC = 0.71 with NIFNB ) to the final
analysis because of their strong correlation with the feature NIFNB . Many studies
have implicated CD8+ T cells more commonly than CD4+ T cells in the patho-
genesis of ECM [33,134–137]. Therefore, out of the other strongly correlated pair
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TABLE6.2 Pearson correlation coefficient between individual features and the class vari-
able.
The value 1 denotes total positive linear correlation, 0 is no linear correlation,
and −1 stands for total negative linear correlation.

















of PCD8S and PCD4S (PCC = 0.88), only one feature namely PCD8S is added to the final
feature set. As a result, by selecting a feature subset that contains features that are
relevant to the dependant variable and also non-redundant [133, 138], size of the
feature space of 16 features (as measured in the experiment) is reduced to only 5.





























































































FIGURE 6.1 Pearson correlations coefficients within pairs of features
Spheres colored in shades of red denote negative correlation, spheres colored in
shades of blue denote negative correlation and their sizes denote the magnitude
of correlation.
the dataset. Thus we are left with 47 observations of 5 features each. To begin
with, all features are standardized to have zero mean and unit standard deviation.
In doing so, it is ensured that all features are treated equally in the learning process
irrespective of their absolute range.
6.3.3 Model selection using cross validation and regularization
The search for optimal regularization parameter and model selection is de-
scribed in the following steps:
• Step 1: The data is randomly partitioned into a training set (80%) and a
testing set (20%).
• Step 2: A5-fold cross validation is applied on the training dataset that yields

























FIGURE 6.2 Schematic showing the 4 steps of learning from the dataset and validating
the learned model
In the first step, data is split into a training set and a testing set. In the second step,
the best model and the optimum value for hyper-parameter λ is selected using a
k-fold cross validation. This model is then parameterized using the full training
set. The trained model is then validated by evaluating model performance on the
testing set using AUC as the criterion. This schematic is a derivative of a figure by
Sebastian Raschka licensed under Creative CommonsAttribution 4.0 International
License.
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• Step 3: Taking the best value for λ (from Step 2), the complete training
dataset is used to generate the final model.
• Step 4: The final model is then validated against the testing dataset that was
set aside in the first step and various performancemetrics are calculated. See
Fig. 6.2
6.4 Results
With the objective of finding the most relevant features of the dataset that are
sufficient to classify the mice into the ones that develop ECM and the ones that
do not via logistic regression and machine learning, the steps explained in section
6.3.3 were implemented. The steps were repeated 5000 times so that learning takes
place on various combinations of training and testing data-sets, the best model
as an output of each run was logged. Out of these 5000 best models, the model
that appeared most frequently in the log as the best in that run was considered
as the final best model and comparisons were made to two of the next frequently
appearing models to assure that the learning was indeed unbiased and that it lead
to a global best model.
TABLE 6.3 Models and the features selected most frequently
Features in the models A (selected most frequently), B (selected second most
frequently) and C (selected third most frequently) in 5000 runs.
Model Feature 1 Feature 2 Feature 3 Feature 4
A NIFNB PCD8S NCD8B -
B NIFNB PCD8S NCD8B NCD4B
C NIFNB PCD8S NCD4B -
The three most frequently selected models are listed in Table6.3. The features
NIFNB and PCD8S emerge as relevant features in all the three models. Evidently, the
ROC and AUC of these models also exhibit that these models as classifiers are ca-
pable in distinguishing the ECMmice from the non-ECMmice (see Fig. 6.3). The










































FIGURE 6.3 Best receiver operator characteristics (ROC) of the various models
(A). model A (AUC = 0.94), (B). model B (AUC = 0.89) and (C). model C (AUC
= 0.83).
TABLE 6.4 Features and their frequency of being selected as relevant features
Features and their frequency of being selected as relevant features across
all the 5000 models for various training data and testing data combinations.





Rest of the features < 20 %
of model A and model B are quite comparable (see Fig. 6.3). However, model
A, being the parsimonious of the two models, is selected as the best performing
model. The coefficients of features estimated by fitting a logistic regression model
with a regularization parameter λ = 0.13 to the entire dataset are shown in Table
6.5.
The probability of developing ECM given the three features (see Table 6.5)
selected by model A is plotted against the model output (z, as seen in Eq. (2.2)) for
the data from all the six groups of mice (two uninfected control groups sporozoite
or iRBC injected, two KO infected groups sporozoite or iRBC injected, and two
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FIGURE 6.4 Output of the classifier
Triangles denote data from mice that were infected via sporozoites, circles denote
data from mice that were infected via iRBCs. Data from mice that were observed
to have developed ECM are coloured in green, and the ones that didn’t are in blue.
The three horizontal lines are the three decision thresholds. Inset shows a zoomed
version of the classifier output for data that yielded model output -1 < z < 0. The
numbers on top or bottom represent mouse IDs for WT or KO respectively.
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estimated coefficients in Table 6.5 in Fig. 6.4. An ideal classifier output would
have shown a definite separation between the two groups being classified (here, it
would have meant the green and blue data-points in Fig. 6.4 being separated on the
curve with no overlaps). Instead, the plot shows three obviously distinct regions in
the classifier output. The region z ≤ −1 is populated by the model output for data
from both the control groups, all of which are rightly classified as non-infected
by the classifier. The region on the other extreme, z ≥ 0 contains model output
for mice that were infected by WT iRBCs and are correctly classified as ECM
developing. However the region −1 < z < 0 that is occupied by mice infected by
WT sporozoites or KO sporozoites or KO iRBCs shows a lot of misclassification.
The decision threshold (τ ) or the criterion to convert the probability of ECMwhich
is the outcome of logistic regression into actual class namely ECM or non-ECM
depends highly on the data used for learning (see Eq: (6.1)).
ŷi =
1 (ECM); for p(yi = 1|xi) ≥ τ0 (non-ECM); for p(yi = 1|xi) < τ (6.1)
TABLE 6.6 Decision threshold and its impact on performance of the classifier
Decision threshold (τ ) Accuracy (ACC) Sensitivity (SEN ) Specificity (SPEC)
0.5 83 % 50 % 100 %
0.25 70 % 100 % 45 %
0.35 85 % 75 % 90 %
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TABLE 6.7 Table showing confusion matrix for model A with τ = 0.35
Predicted
ECM No ECM Total
Actual
ECM 12 4 16
No ECM 3 28 31
Total 15 32 47
In this case, the data is imbalanced, meaning that there are more cases of one
class (non-ECM mice) than that of the other class (ECM mice). When the class
sizes are not equal, the derived classifier favors the larger class [61]. This can be
seen in Fig. 6.4, if τ is set to 0.5, all of the members of the non-ECM class, the
larger of the two classes, are rightly classified. As discussed earlier the choice of
opting a better sensitivity over specificity or vice-versa or opting for acceptable
levels of both is governed the objective of the classifier in that particular real-life
application. Here the aim is to develop a classifier that is adequately sensitive in
detecting the ”1” or ”positive” class as well as adequately specific in detecting the
”0” or ”negative” class [61]. A number of decision thresholds (τ ) were tested with
the global best model and the classifier performance terms of accuracy, sensitivity
and specificity were compared for each threshold. A value of τ = 0.35 lead to the
best performing classifier (see Table 6.6 and 6.7)
6.5 Discussion
In this chapter, I take a machine learning approach to determine the processes
that may contribute to cerebral inflammation, a severe outcome of some of the
Malarial infections. In the experiment described in Subsection 2.2.3, a number
of indicators of immune activation and immune migration to the brain were mea-
sured. Here, I used the measured data to find a subset of these indicators that are
adequate in predicting if a mouse from the experiment developed ECM or not. A
classifier based on logistic regression was trained on the data and of all the 16 mea-
sured indicators of immune activity in the spleen and brain 3 variables; namely 1)
the number of CD8+ T cells isolated from the brain, 2) the proportion of CD8+ T
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cells in lymphocytes isolated from the spleen and 3) the number of Pb1-specific
IFN-γ+ CD8+ T cells in the brain emerge as the most significant characteristics
that can distinguish a mouse with ECM from a mouse without ECM.
The liver-stage followed by the blood-stage ofPlasmodium infection cause two
separate (one by each stage) innate immune responses to counter parasite replica-
tion and subsequent spread of the disease. The parasites are sequestered in blood
vessels leading to a reduced blood flow thereby restricting the delivery of oxygen
and nutrients to the brain and other organs. In addition to this, the accumulated
parasitized RBCs lead to endothelial activation thereby increasing the binding abil-
ity of the endothelial cells. The activated endothelium becomes a site of further
accumulation of leukocytes and RBCs. Upon reaching there, the leukocytes them-
selves secrete cytokines and chemokines that promote even more recruitment of
inflammatory cells. Such an onslaught of inflammatory cells leads to a permeable
endothelial wall and the blood-brain barrier is disrupted. The pro-inflammatory
cells now have access to the brain and start the same feedforward loop of more
recruitment and inflammation in the brain. A detailed understanding of the exact
molecular processes underlying development of ECM is still lacking as to which of
the leukocytes play a pivotal role and which chemokines or cytokines are directly
involved in causing the neuropathology [33].
It has been observed that dendritic cell (DC) primed CD8+ T cells in the spleen
peak around 4 day post infection inmice infectedwithPlasmodium bergheiANKA
and show a decrease in their proportion probably because of migration to the brain
around 7 day post infection, the day when the onset of cerebral inflammation takes
place [139]. This coincides with our conclusion that a change in the proportion of
CD8+ T cells around the day when mice infected with WT strain showed acute
ECM symptoms is an important indicator (PCD8S appears as a significant feature
in models A,B and C) of ECM development. The proportion of CD8+ T cells is
drastically reduced in the mice infected via WT iRBCs as compared to the control
uninfected mice and the mice infected via KO iRBCs. However, this proportion
is comparable between the mice infected with KO sporozoites or WT sporozoites,
even though both the groups show a reduced proportion as compared to the con-
trol mice. CD8+ T cells have been implicated in many studies in cerebral im-
munopathalogy [33, 135–137]. After reaching the brain, cytotoxic CD8+ T cells
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are exposed to parasite antigens cross-presented by the activated endothelial cells,
thereby contributing to heightened inflammation and further disruption of blood-
brain barrier. The number of CD8+ T cells isolated from the brain therefore is
another significant feature of our classifier. Not just the best model (model A in
Table 6.3), but also the second in rank of all the models (model B in Table 6.3)
implicates the presence of CD8+ T cells in the brain. In the model C, the feature
NCD8B is replaced by NCD4B which is an artefact of random partitioning of data into
test and train sets and some combinations of data points in the learning or train
set can lead to an inference that NCD4B is also an important factor in ECM. Given
the fact that NCD8B and NCD4B are correlated in the data, the algorithm sometimes
chooses one over the other or both as in the case of model C. The last and the most
significant feature in all the three classifiers A, B, and C is the number of CD8+ T
cells isolated from brain that respond to Pb1 stimulation. There is ample evidence
in various studies [140–142] that not just the availability of CD8+ T cells but the
existence of Malaria specific CD8+ IFN-γ+ T cells contributes to ECM outcome.
In fact Shaw et al in [143] found that there were comparable numbers of CD8+
T cells sequestered in the brains of mice infected with ECM causing strain and
non ECM causing strain. They recorded that these two groups however differed
in the secondary activation of CD8+ T cells in brain to parasite specific antigen
stimulus. The interaction of the infiltrating CD8+ T cells with specific antigens is
distinct in ECM as compared to non ECM infection. Thus it is only logical that
NIFNB emerges as a feature of prime significance in our proposed classifier.
Although the classifier proposed here performs with a 100% accuracy in clas-
sifying the mice in two control groups, KO-iRBC infected into non-ECM class
and WT -iRBC into ECM class, a sizeable proportion of KO-sporozoite infected
and WT-sporozoite infected groups remain misclassified. This shortcoming of the
classifier can be attributed to 1). noise in the data or 2). to another ECM contribut-
ing factor that has been overlooked in the experiment. It is quite unlikely that the
measurements are noisy given the fact that mice with IDs 1,3,6 and 9 in the WT-
sporozite infected, mice with IDs 8 and 10 in the KO-sporozoite and mouse with
ID 1 in the KO-iRBC infected behave differently to the majority of their group
members but still have a behaviour common to other outlying members of their
own group. Assuming that there is indeed a contributing factor that the classifier
90
fails to consider, I searched for conclusions drawn in other experimental studies
to justify this assumption.
As discussed before, it is the secondary activation of CD8+ T cells (that infil-
trated the brain following priming in the spleen) that is a major cause of inflam-
mation in the brain. The secondary activation is in response to the cross- presen-
tation of antigens by iRBCs sequestered in the brain. Therefore, apart from the
pro-inflammatory CD8+ T cells causing damage in the brain, the accessibility of
parasite material to these cells must also be the driving force behind the extent of
damage [142,143]. It is known that peripheral parasitemia is closely correlated to
the magnitude of iRBCs sequestered in the brain vessels [58,144]. Similarly, par-
asite strains causing ECM cause a heightened level of parasitezed RBCs in brains
of mice as compared to the non-ECM causing strains [144]. Hence, even though
WT or KO sporozoite infected mice show comparable levels of CD8+ T cell infil-
tration and the isolated CD8+ T cells show similar response to Pb1 stimulus, the
KO sporozoite infected mice have in fact lower peripheral parasitemia levels, that
correspond to lower parasite material sequestered in the brain leading to a dimin-
ished stimulus to the CD8+ T cells in brain. This explains the less severe disease
outcome in KO sporozoite infected mice and serious cerebral implications in WT
sporozoite infected mice. In summary our analysis backs the claim that it is not
one of the two hypotheses of ECM immunopathogenesis namely vascular occlu-
sion and inflammation [128], but an intricate combination of both the hypotheses,
the peak peripheral parasitemia, the obstruction of the vascular system by para-
sitized RBCs, change in the CD8+ T cell proportion in the spleen, migration of
primed CD8+ T cells to the brain, the degree of CD8+ IFN-γ+ T cell response to
the antigen Pb1, is responsible as a whole for cerebral inflammation during Plas-
modium berghei ANKA infection in mice.
6.6 Conclusion
This study proposes an ECM pathogenesis hypothesis on a macro level. The
proposed hypothesis is based on finding certain characteristics of immune activa-
tion and immunemigration to the brain that are specific to the parasite strain (ECM
or non-ECM causing). It also brings to home the point that route of infection is
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not the deciding factor for disease outcome, meaning WT infection leads to ECM
and KO infection does not irrespective of the route of infection. However, the
triggered immune response and the consequent inflammation in the brain is spe-
cific to route of infection. The data showed the highest immune responses being
triggered during WT infection when the liver-stage was bypassed, and the least
during KO infection via iRBCs, the latter one being the most unnatural route. The
responses were comparable when both liver-stage and blood-stage were executed
for WT and KO infections, which also lead to a less accurate classifier for these
two groups. These comparable groups can still be classified into ECM and non
ECM classes, if the feature space is extended to include one of the indicators of
parasitemia be it peripheral parasitemia or the extent of iRBC infiltration in the
brain. To sum it all up, our work is another proof to the idea that it is the combined
effect of parasite sequestration in the brain and the level of pro-inflammatory cells




The overall objective of this thesis was to understand within-host infection
dynamics of Malaria and finding factors that decide the fate of disease severity.
Mechanistic within-host models that describe progression of infection at various
stages of the parasite life-cycle were developed. Through these models, the infec-
tion parameters of PbANKA (WT) and PbmaLS_05(-) (KO) strains were distin-
guished leading to conclusions about the potential role of PbmaLS_05 in cerebral
Malaria.
While modeling the blood-stage infection dynamics of Malaria, it was dis-
covered that Malaria induced change in erythropoiesis is a characteristic of early
infection, even before substantial loss of RBCs to parasite invasion has occurred.
This altered erythropoietic dynamics is a major contributor to reduction in retic-
ulocyte population. This finding is corroborated by other studies [19, 78, 145],
that report disease induced suppression of RBC production, although in [19] it
is observed only during the later phase of infection. The blood-stage infection
dynamics model revealed that lower parasitemia observed during KO infection is
attributed to its lower average infectivity than the WT strain. In addition to this, it
was found that similar to other more infectious Plasmodium strains [12,15,16,19],
the PbANKA (WT) strain infects the reticulocytes with a higher rate of infection
than it infects the normocytes. On further analysis that was based on testing vari-
ous hypotheses using the model and including the data from the PHZ experiment,
I concluded that the KO strain displays little or no preference for infecting reticu-
locytes as compared to the normocytes. Thus, PbmaLS_05 potentially plays a role
in infecting reticulocytes and its deletion results in reduced parasitemia, which
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eventually causes only severe anemia and not experimental cerebral Malaria.
In addition to rate of infection and reticulocyte preference, it was also explored
if other characteristics of Malaria blood-stage infection, like reduced merozoite
production or altered maturation times for infected RBCs could explain the re-
duced parasitemia in KO infected mice. This indicated that a maturation time that
is approximately twice as long than the WT-iRBC could be a possible reason for
the observed KO infection dynamics. This supports the conclusion that deletion
of PbmaLS_05 particularly leads to impaired parasite development and less suc-
cessful infections in reticulocytes during the initial blood-stage phase.
With the combination of experimental data and within-host model, only a com-
parative study between the infection dynamics of the two strains was possible. The
next step can be to determine absolute values of their infection rates and reticulo-
cyte preferences. A similar blood-stage infection experiment that records changes
in the blood plasma concentration and proportion of infected reticulocytes, in addi-
tion to total RBC proportion, proportion of reticulocytes and proportion of infected
reticulocytes, will enhance the analysis further. Similarly, more complex models
that can test various hypotheses like changing reticulocyte preference over time
and preference for a particular age of RBCs, not restricting to classifying RBCs
into reticulocytes and normocytes can be developed and used to further character-
ize PbmaLS_05.
The investigation of early blood-stage Malaria infection dynamics established
that knocking out the PbmaLS_05 renders the KO strain weaker in productive in-
fection and severe disease progression in comparison to the WT strain. This lead
to the next natural question, how would such a weakness manifest itself during
the liver stage. It was observed that the KO sporozoites when used to infect mice
showed a slight developmental delay while maturing and multiplying in the liver
[13]. Many studies have reported that Plasmodium development inside the host
liver is coupled with the availability of nutrition to the parasite [24, 27, 102] and
nutritional status of the host [25,26]. PbmaLS_05 is known to localize to the api-
coplast [13], the organelle that contributes towards metabolite synthesis [118].
Thus, a proof-of-concept study that quantified the impact of host nutritional sta-
tus on the development of Plasmodium during Malaria infection was done. This
analysis was further used to develop an experimental protocol that could be used
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to:
1) Magnify the developmental delay (if any) in the KO sporozoites, by observ-
ing WT and KO infection dynamics in pre-starved hosts.
2) Characterize the role of PbmaLS_05 gene more precisely during the pre-
erythrocytic liver-stage.
A detailed understanding of how extent of peripheral parasitemia and the trig-
gered immune responses during the progression ofMalaria through various within-
host stages is still not available [33]. A comparison of immune activation and
immune response data from the KO (non-ECM causing) or WT (ECM causing)
infected mice resulted in selecting major contributors to cerebral Malaria. The
classifier based method revealed that the number of CD8+ T cells in the brain was
the most significant indicator for the development of cerebral Malaria in mice.
Studies have highlighted that CD8+ T cells found in the brain during the infec-
tion are indeed responsible for cerebral immunopathology [139]. Additionally,
PbANKA WT infection is known to cause a peak in the proportion of CD8+ T
cells in leukocytes in the spleen, followed by a drastic reduction in the proportion
around the day when infected mice show ECM symptoms [33, 135–137]. Like-
wise, the comparative analysis done here, also suggests the proportion of CD8+ T
cells in the spleen as the next important player in causing cerebral Malaria. Along
with these two, it was found here that not just the availability of CD8+ T cells
in the brain but also the presence of Malaria specific CD8+ IFN-γ+ T cells pro-
duces cerebral symptoms [140–142]. Notably, the limitation of this method in
distinguishing some mice from the other displayed that the measured signatures of
immune response and immune activation were not sufficient in predicting the dis-
ease outcome for a given mouse. However, this missing link can be guessed with
a very high probability from the analysis. The CD8+ T cells, that infiltrated the
brain after priming in the spleen, undergo secondary activation in the presence of
antigens cross-presented by iRBCs sequestered in the brain [58,142–144]. Thus,
assuming that the number of iRBCs sequestered in the brain are proportional to
peripheral parasitemia, the extent of parasitemia in the blood must definitely be a
major indicator of ECM.
All of these four factors perfectly justify why PbANKAWT infected mice, via
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sporozoites or iRBCs developed ECM, whereas the PbmaLS_05 (-) KO infected
mice via sporozoites or iRBCs did not develop ECM, in-spite of the KO-sporozoite
infected mice showing comparable levels of immune response to that of the WT.
Thus, bringing home the point that PbmaLS_05 may not have an important role
to play in triggered immune response during the liver-stage of Malaria. However,
its absence may lead to a small developmental delay during the liver-stage, which
must be further investigated. Besides this, it is evident from the analysis that dur-
ing the blood-stagePbmaLS_05 contributes in reticulocyte invasion/infection, and
knocking it out makes the parasite non-specific to the age of its target red blood
cell. I propose that the PbmaLS_05 (-) mutant parasite strain can serve as a tool to
study how the preference of parasites to infect particular RBC influences both dis-
ease progression and the development of experimental cerebral Malaria. This will
ultimately aid in discovering the factors that influence the activation of immune
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FIGURE A.1 Long-term dynamics of the KO-parasite strain followed for 20days post
infection when mice develop anemia
The data for the reticulocyte proportion (A) and the parasitemia (B) is shown in
grey. The green line indicates the prediction of the mathematical model for the
KO infection parameters when fitted to the acute infection dynamics (day 0-4 p.i.,
lower panels). The model is incapable in explaining the observed increase in retic-
ulocyte proportion and parasitemia at later days of infection. This indicates a po-
tential change in the assumed processes regulating erythropoiesis during the later





































FIGURE B.1 Parasite fitness P (t) as predicted for the three starvation groups relative to
































FIGURE B.2 Parasite fitness P (t) as predicted for the three starvation groups relative to






























































































































FIGURE C.1 Immune status data I
The left panel shows data from mice infected with iRBC injections, and the right
panel shows data from mice infected with sporozoites. The colors indicate the
three groups, namely red: control, blue: KO and green: WT. The boxplot corre-
sponds to the first and third quartiles and the median. It is evident that there is
no single factor that is decisive indicator of ECM in mice. A detailed analysis
revealed that it is a linear combination of CD8+ T cells found in the brain, the pro-
portion of CD8+ T cells in the spleen and the presence of Malaria specific CD8+
IFN-γ+ T, that are major indicators of ECM.
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FIGURE C.2 Immune status data II
The left panel shows data from mice infected with iRBC injections, and the right
panel shows data from mice infected with sporozoites. The colors indicate the
three groups, namely red: control, blue: KO and green: WT. The boxplot corre-
sponds to the first and third quartiles and the median. It is evident that there is
no single factor that is decisive indicator of ECM in mice. A detailed analysis
revealed that it is a linear combination of CD8+ T cells found in the brain, the pro-
portion of CD8+ T cells in the spleen and the presence of Malaria specific CD8+
IFN-γ+ T, that are major indicators of ECM.
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FIGURE C.3 Immune status data III
The left panel shows data from mice infected with iRBC injections, and the right
panel shows data from mice infected with sporozoites. The colors indicate the
three groups, namely red: control, blue: KO and green: WT. The boxplot corre-
sponds to the first and third quartiles and the median. It is evident that there is
no single factor that is decisive indicator of ECM in mice. A detailed analysis
revealed that it is a linear combination of CD8+ T cells found in the brain, the pro-
portion of CD8+ T cells in the spleen and the presence of Malaria specific CD8+
IFN-γ+ T, that are major indicators of ECM.
105
Bibliography
[1] W. H. Organization, “World malaria report 2017,” World Health Organiza-
tion, Geneva, Tech. Rep., 2017.
[2] R. Idro, K.Marsh, C. C. John, and C. R. Newton, “Cerebral malaria: mecha-
nisms of brain injury and strategies for improved neurocognitive outcome,”
Pediatric research, vol. 68, no. 4, p. 267, 2010.
[3] A. Olotu, G. Fegan, J. Wambua, G. Nyangweso, A. Leach, M. Lievens,
D. C. Kaslow, P. Njuguna, K. Marsh, and P. Bejon, “Seven-year efficacy of
rts, s/as01 malaria vaccine among young african children,” New England
Journal of Medicine, vol. 374, no. 26, pp. 2519–2529, 2016.
[4] T. Annoura, I. H. Ploemen, B. C. van Schaijk, M. Sajid, M. W. Vos, G.-J.
van Gemert, S. Chevalley-Maurel, B. M. Franke-Fayard, C. C. Hermsen,
A. Gego et al., “Assessing the adequacy of attenuation of genetically mod-
ified malaria parasite vaccine candidates,” Vaccine, vol. 30, no. 16, pp.
2662–2670, 2012.
[5] R. E. Sinden, “Developing transmission-blocking strategies for malaria
control,” PLoS pathogens, vol. 13, no. 7, p. e1006336, 2017.
[6] E. Tjitra, N. M. Anstey, P. Sugiarto, N. Warikar, E. Kenangalem,
M. Karyana, D. A. Lampah, and R. N. Price, “Multidrug-resistant plasmod-
ium vivax associated with severe and fatal malaria: a prospective study in
papua, indonesia,” PLoS medicine, vol. 5, no. 6, p. e128, 2008.
106
[7] C. Metcalf, G. Long, N. Mideo, J. Forester, O. Bjørnstad, and A. Graham,
“Revealing mechanisms underlying variation in malaria virulence: effec-
tive propagation and host control of uninfected red blood cell supply,” Jour-
nal of The Royal Society Interface, p. rsif20120340, 2012.
[8] I. Coppens, “Metamorphoses of malaria: the role of autophagy in parasite
differentiation,” Essays in biochemistry, vol. 51, pp. 127–136, 2011.
[9] G. Siciliano and P. Alano, “Enlightening the malaria parasite life cycle: bi-
oluminescent plasmodium in fundamental and applied research,” Frontiers
in microbiology, vol. 6, p. 391, 2015.
[10] A. G. Craig, G. E. Grau, C. Janse, J. W. Kazura, D. Milner, J. W. Barnwell,
G. Turner, J. Langhorne et al., “The role of animal models for research on
severe malaria,” PLoS pathogens, vol. 8, no. 2, p. e1002401, 2012.
[11] M. Niikura, S.-I. Inoue, T. Fukutomi, J. Yamagishi, H. Asahi, and
F. Kobayashi, “Comparative genomics and proteomic analyses between
lethal and nonlethal strains of plasmodium berghei,” Experimental para-
sitology, vol. 185, pp. 1–9, 2018.
[12] R. Antia, A. Yates, and J. C. de Roode, “The dynamics of acute malaria
infections. i. effect of the parasite’s red blood cell preference,” Proc Biol
Sci, vol. 275, no. 1641, pp. 1449–58, 2008.
[13] P. Fernandes, S. Howland, K. Heiss, A. Hoffmann, M. A. Hernandez-
Castaneda, K. Vochyanova, R. Frank, P. Wiedemann, M. Bendszus, L. Ré-
nia et al., “A plasmodium cross-stage antigen contributes to the develop-
ment of experimental cerebral malaria,” Frontiers in Immunology, vol. 9,
p. 1875, 2018.
[14] D. Cromer, J. Stark, and M. P. Davenport, “Low red cell production may
protect against severe anemia during a malaria infection—insights from
modeling,” Journal of theoretical biology, vol. 257, no. 4, pp. 533–542,
2009.
107
[15] B. Mons, “Preferential invasion of malarial merozoites into young red
blood cells,” Blood Cells, vol. 16, no. 2-3, pp. 299–312, 1990. [Online].
Available: http://europepmc.org/abstract/MED/2257316
[16] B. Mons, J. J. Croon, W. van der Star, and H. J. van der Kaay,
“Erythrocytic schizogony and invasion of plasmodium vivax in vitro,”
Int J Parasitol, vol. 18, no. 3, pp. 307–11, 1988. [Online]. Available:
http://www.ncbi.nlm.nih.gov/pubmed/3294199
[17] R. J. Wilson, G. Pasvol, and D. J. Weatherall, “Invasion and growth of
plasmodium falciparum in different types of human erythrocyte,” Bull
World Health Organ, vol. 55, no. 2-3, pp. 179–86, 1977. [Online].
Available: http://www.ncbi.nlm.nih.gov/pubmed/338178
[18] I. Singer, R. Hadfield, and M. Lakonen, “The influence of age on the inten-
sity of infection with plasmodium berghei in the rat,” J Infect Dis, vol. 97,
no. 1, pp. 15–21, 1955.
[19] D. Cromer, K. J. Evans, L. Schofield, and M. P. Davenport, “Preferential
invasion of reticulocytes during late-stage plasmodium berghei infection
accounts for reduced circulating reticulocyte levels,” Int J Parasitol,
vol. 36, no. 13, pp. 1389–97, 2006. [Online]. Available: http://www.ncbi.
nlm.nih.gov/pubmed/16979643
[20] F. E. McKenzie, G. M. Jeffery, and W. E. Collins, “Plasmodium vivax
blood-stage dynamics,” Journal of Parasitology, vol. 88, no. 3, pp. 521–
535, 2002.
[21] D. H. Kerlin andM. L. Gatton, “Preferential invasion by plasmodiummero-
zoites and the self-regulation of parasite burden,” PLoS One, vol. 8, no. 2,
p. e57434, 2013.
[22] P. G. McQueen and F. E. McKenzie, “Age-structured red blood cell suscep-
tibility and the dynamics of malaria infections,” Proc Natl Acad Sci U S A,
vol. 101, no. 24, pp. 9161–6, 2004.
108
[23] B. Jayabalasingham, R. Menard, and D. A. Fidock, “Recent insights into
fatty acid acquisition and metabolism in malarial parasites,” F1000 biology
reports, vol. 2, 2010.
[24] C. Agop-Nersesian, L. Niklaus, R.Wacker, andV. TheoHeussler, “Host cell
cytosolic immune response during plasmodium liver stage development,”
FEMS microbiology reviews, vol. 42, no. 3, pp. 324–334, 2018.
[25] M.-N. Lombard, R. Bazin, G. Durand, F. Beaugé, D. Baccam, F. Milgen,
and I. Landau, “Rodent plasmodium development in livers of genetically
obese zucker rats (fa/fa),” European Journal of Protistology, vol. 34, no. 1,
pp. 78–81, 1998.
[26] M. Prado, N. Eickel, M. D. Niz, A. Heitmann, C. Agop-Nersesian,
R. Wacker, J. Schmuckli-Maurer, R. Caldelari, C. J. Janse, S. M.
Khan, J. May, C. G. Meyer, and V. T. Heussler, “Long-term live
imaging reveals cytosolic immune responses of host hepatocytes against
plasmodium infection and parasite escape mechanisms,” Autophagy,
vol. 11, no. 9, pp. 1561–1579, 2015, pMID: 26208778. [Online]. Available:
https://doi.org/10.1080/15548627.2015.1067361
[27] C. Thieleke-Matos, M. Lopes da Silva, L. Cabrita-Santos, M. D. Portal,
I. P. Rodrigues, V. Zuzarte-Luis, J. S. Ramalho, C. E. Futter, M. M. Mota,
D. C. Barral et al., “Host cell autophagy contributes to plasmodium liver
development,” Cellular microbiology, vol. 18, no. 3, pp. 437–450, 2016.
[28] M. J. Shears, C. Y. Botté, and G. I. McFadden, “Fatty acid metabolism in
the plasmodium apicoplast: Drugs, doubts and knockouts,”Molecular and
biochemical parasitology, vol. 199, no. 1-2, pp. 34–50, 2015.
[29] C. Bisanz, O. Bastien, D. Grando, J. Jouhet, E. Maréchal, and M.-F.
Cesbron-Delauw, “Toxoplasma gondii acyl-lipid metabolism: de novo syn-
thesis from apicoplast-generated fatty acids versus scavenging of host cell
precursors,” Biochemical Journal, vol. 394, no. 1, pp. 197–205, 2006.
109
[30] S. Mundhra, U. Parmar, and D. Shukla, “A prospective study to identify
the co-relation of a disease severity of complicated malaria & clinical out-
come,” Paripex-Ind J Res, vol. 12, no. 4, p. 7, 2016.
[31] A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N.White, “Artesunate
versus quinine for treatment of severe falciparum malaria: a randomised
trial.” Lancet (London, England), vol. 366, no. 9487, pp. 717–725, 2005.
[32] L. Cui, S. Mharakurwa, D. Ndiaye, P. K. Rathod, and P. J. Rosenthal, “Anti-
malarial drug resistance: literature review and activities and findings of the
icemr network,” The American journal of tropical medicine and hygiene,
vol. 93, no. 3_Suppl, pp. 57–68, 2015.
[33] J. Dunst, F. Kamena, and K. Matuschewski, “Cytokines and chemokines in
cerebral malaria pathogenesis,” Frontiers in cellular and infection microbi-
ology, vol. 7, p. 324, 2017.
[34] N. J. White, G. D. Turner, I. M. Medana, A. M. Dondorp, and N. P.
Day, “The murine cerebral malaria phenomenon,” Trends in parasitology,
vol. 26, no. 1, pp. 11–15, 2010.
[35] F. E. McKenzie, “Why model malaria?” Parasitology Today, vol. 16,
no. 12, pp. 511–516, 2000.
[36] R. Ross, “Some a priori pathometric equations,” British medical journal,
vol. 1, no. 2830, p. 546, 1915.
[37] A. M. Dondorp, S. Yeung, L. White, C. Nguon, N. P. Day, D. Socheat, and
L. Von Seidlein, “Artemisinin resistance: current status and scenarios for
containment,” Nature Reviews Microbiology, vol. 8, no. 4, p. 272, 2010.
[38] N. J. White, “Antimalarial drug resistance,” The Journal of clinical inves-
tigation, vol. 113, no. 8, pp. 1084–1092, 2004.
[39] M. L. Gatton and Q. Cheng, “Modeling the development of acquired clini-
cal immunity to plasmodium falciparum malaria,” Infection and immunity,
vol. 72, no. 11, pp. 6538–6545, 2004.
110
[40] K. Dietz, G. RADDATZ, and L. Molineaux, “Mathematical model of the
first wave of plasmodium falciparum asexual parasitemia in non-immune
and vaccinated individuals,” The American journal of tropical medicine and
hygiene, vol. 75, no. 2_suppl, pp. 46–55, 2006.
[41] R. Anderson, R. May, and S. Gupta, “Non-linear phenomena in host—
parasite interactions,” Parasitology, vol. 99, no. S1, pp. S59–S79, 1989.
[42] D. S. Khoury, D. Cromer, S. E. Best, K. R. James, P. S. Kim, C. R. En-
gwerda, A. Haque, and M. P. Davenport, “Effect of mature blood-stage
plasmodium parasite sequestration on pathogen biomass in mathematical
and in vivo models of malaria,” Infection and immunity, vol. 82, no. 1, pp.
212–220, 2014.
[43] C. Dogovski, S. C. Xie, G. Burgio, J. Bridgford, S. Mok, J. M. McCaw,
K. Chotivanich, S. Kenny, N. Gnädig, J. Straimer et al., “Targeting the cell
stress response of plasmodium falciparum to overcome artemisinin resis-
tance,” PLoS biology, vol. 13, no. 4, p. e1002132, 2015.
[44] C. Chiyaka, W. Garira, and S. Dube, “Modelling immune response and
drug therapy in human malaria infection,” Computational and Mathemati-
cal Methods in Medicine, vol. 9, no. 2, pp. 143–163, 2008.
[45] M. A. Selemani, L. S. Luboobi, and Y. Nkansah-Gyekye, “The in-human
host and in-mosquito dynamics of malaria parasites with immune re-
sponses,” New Trends in Mathematical Sciences, vol. 5, no. 3, pp. 182–207,
2017.
[46] T. O. Orwa, R. W. Mbogo, and L. S. Luboobi, “Mathematical model for
hepatocytic-erythrocytic dynamics of malaria,” International Journal of
Mathematics and Mathematical Sciences, vol. 2018, 2018.
[47] Z. Tabo, L. S. Luboobi, and J. Ssebuliba, “Mathematical modelling of the
in-host dynamics of malaria and the effects of treatment,” Journal of Math-
ematics and computer science-JMCS, vol. 17, no. 1, pp. 1–21, 2017.
111
[48] M. Prudêncio, M. M. Mota, and A. M. Mendes, “A toolbox to study liver
stage malaria,” Trends in parasitology, vol. 27, no. 12, pp. 565–574, 2011.
[49] T. Davis, S. Krishna, S. Looareesuwan, W. Supanaranond, S. Pukrit-
tayakamee, K. Attatamsoonthorn, and N. J. White, “Erythrocyte seques-
tration and anemia in severe falciparum malaria. analysis of acute changes
in venous hematocrit using a simple mathematical model.” The Journal of
clinical investigation, vol. 86, no. 3, pp. 793–800, 1990.
[50] E. Alpaydin, Introduction to machine learning. MIT press, 2009.
[51] M. Poostchi, K. Silamut, R. Maude, S. Jaeger, and G. Thoma, “Image anal-
ysis and machine learning for detecting malaria,” Translational Research,
2018.
[52] S. Mavandadi, S. Dimitrov, S. Feng, F. Yu, U. Sikora, O. Yaglidere, S. Pad-
manabhan, K. Nielsen, and A. Ozcan, “Distributed medical image analysis
and diagnosis through crowd-sourced games: a malaria case study,” PloS
one, vol. 7, no. 5, p. e37245, 2012.
[53] G. Díaz, F. A. González, and E. Romero, “A semi-automatic method for
quantification and classification of erythrocytes infected with malaria par-
asites in microscopic images,” Journal of Biomedical Informatics, vol. 42,
no. 2, pp. 296–307, 2009.
[54] Y. KalantarMotamedi, R. T. Eastman, R. Guha, and A. Bender, “A system-
atic and prospectively validated approach for identifying synergistic drug
combinations againstmalaria,”Malaria journal, vol. 17, no. 1, p. 160, 2018.
[55] J. Y. Mary, A. J. Valleron, H. Croizat, and E. Frindel, “Mathematical anal-
ysis of bone marrow erythropoiesis: application to c3h mouse data,” Blood
Cells, vol. 6, no. 2, pp. 241–62, 1980.
[56] N. Thakre, P. Fernandes, A.-K. Mueller, and F. Graw, “Examining
the reticulocyte preference of two plasmodium berghei strains during
blood-stage malaria infection,” Frontiers in Microbiology, vol. 9, p. 166,
112
2018. [Online]. Available: https://www.frontiersin.org/article/10.3389/
fmicb.2018.00166
[57] B. Franke-Fayard, C. J. Janse, M. Cunha-Rodrigues, J. Ramesar,
P. Büscher, I. Que, C. Löwik, P. J. Voshol, M. A. Den Boer, S. G.
Van Duinen et al., “Murine malaria parasite sequestration: Cd36 is the ma-
jor receptor, but cerebral pathology is unlinked to sequestration,” Proceed-
ings of the National Academy of Sciences, vol. 102, no. 32, pp. 11 468–
11 473, 2005.
[58] H. S. W., P. C. Meng, G. S. Yee, C. Carla, M. Benoit, S. Nilabh,
G. Florent, G. G. M., and R. Laurent, “Brain microvessel cross-
presentation is a hallmark of experimental cerebral malaria,” EMBO
Molecular Medicine, vol. 5, no. 7, pp. 984–999, 2013. [Online]. Available:
https://onlinelibrary.wiley.com/doi/abs/10.1002/emmm.201202273
[59] R Core Team, R: A Language and Environment for Statistical Computing,
R Foundation for Statistical Computing, Vienna, Austria, 2013. [Online].
Available: http://www.R-project.org/
[60] K. Soetaert, T. Petzoldt, and R. W. Setzer, “Solving differential equations
in r: Package desolve,” Journal of Statistical Software, vol. 33, no. 9, pp.
1–25, 2010. [Online]. Available: http://www.jstatsoft.org/v33/i09
[61] J. J. Chen, C. Tsai, H. Moon, H. Ahn, J. J. Young, and C.-h. Chen, “The use
of decision threshold adjustment in classification for cancer prediction,”
2006.
[62] T. Fawcett, “An introduction to roc analysis,” Pattern recognition letters,
vol. 27, no. 8, pp. 861–874, 2006.
[63] C. Gao, H. Sun, T. Wang, M. Tang, N. I. Bohnen, M. L. Müller, T. Her-
man, N. Giladi, A. Kalinin, C. Spino et al., “Model-based and model-free
machine learning techniques for diagnostic prediction and classification of
clinical outcomes in parkinson?s disease,” Scientific reports, vol. 8, no. 1,
p. 7129, 2018.
113
[64] S. Portugal, H. Drakesmith, and M. M. Mota, “Superinfection in
malaria: Plasmodium shows its iron will,” EMBO Rep, vol. 12, no. 12,
pp. 1233–42, 2011. [Online]. Available: http://www.ncbi.nlm.nih.gov/
pubmed/22081142
[65] J. S. Richards and J. G. Beeson, “The future for blood-stage vaccines against
malaria,” Immunology and cell biology, vol. 87, no. 5, pp. 377–390, 2009.
[66] A. M. Dondorp, B. J. Angus, K. Chotivanich, K. Silamut, R. Ruangveer-
ayuth, M. R. Hardeman, P. A. Kager, J. Vreeken, and N. J. White, “Red
blood cell deformability as a predictor of anemia in severe falciparum
malaria,” Am J Trop Med Hyg, vol. 60, no. 5, pp. 733–7, 1999. [Online].
Available: http://www.ncbi.nlm.nih.gov/pubmed/10344643
[67] J. G. Beeson, D. R. Drew, M. J. Boyle, G. Feng, F. J. Fowkes,
and J. S. Richards, “Merozoite surface proteins in red blood cell
invasion, immunity and vaccines against malaria,” FEMS Microbiol
Rev, vol. 40, no. 3, pp. 343–72, 2016. [Online]. Available: http:
//www.ncbi.nlm.nih.gov/pubmed/26833236
[68] M. C. Mackey,Mathematical models of hematopoietic cell replication and
control. New York, NY: Prentice-Hall, 1997, pp. 149–178.
[69] R. M. Bannerman, Hematology, 2nd ed., ser. The Mouse in Biomedical
Research, Normative Biology, Husbandry, and Models. London, UK:
Academic Press, 1983, vol. 3.
[70] A. Ganzoni, R. S. Hillman, and C. A. Finch, “Maturation of the
macroreticulocyte,” Br J Haematol, vol. 16, no. 1, pp. 119–35, 1969.
[Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/5795203
[71] G. Gronowicz, H. Swift, and T. L. Steck, “Maturation of the reticulocyte
in vitro,” J Cell Sci, vol. 71, pp. 177–97, 1984. [Online]. Available:
http://www.ncbi.nlm.nih.gov/pubmed/6097593
[72] P. Wiczling and W. Krzyzanski, “Flow cytometric assessment of
homeostatic aging of reticulocytes in rats,” Exp Hematol, vol. 36, no. 2, pp.
114
119–27, 2008. [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/
18206724
[73] P. Garnham,Malaria Parasites and other Haemosporidia. London, U.K.:
Blackwell Scientific Publishers, 1966.
[74] F. Cox, Major animal models in malaria research: rodents, ser. Malaria:
Principles and Practice of Malariology. Churchill Livingstone, New York,
1988, vol. 2.
[75] J. C. De Roode, “Within-host competition and the evolution of malaria par-
asites,” Thesis, University of Edinburgh, 2004.
[76] H. B. Reilly, H. Wang, J. A. Steuter, A. M. Marx, and M. T. Ferdig,
“Quantitative dissection of clone-specific growth rates in cultured malaria
parasites,” Int J Parasitol, vol. 37, no. 14, pp. 1599–607, 2007. [Online].
Available: http://www.ncbi.nlm.nih.gov/pubmed/17585919
[77] J. L. Villeval, A. Lew, and D. Metcalf, “Changes in hemopoietic and
regulator levels in mice during fatal or nonfatal malarial infections. i.
erythropoietic populations,” Exp Parasitol, vol. 71, no. 4, pp. 364–374,
1990. [Online]. Available: http://www.sciencedirect.com/science/article/
pii/001448949090062H
[78] A. C. Sexton, R. T. Good, D. S. Hansen, M. C. D’Ombrain, L. Bucking-
ham, K. Simpson, and L. Schofield, “Transcriptional profiling reveals sup-
pressed erythropoiesis, up-regulated glycolysis, and interferon-associated
responses in murine malaria,” J Infect Dis, vol. 189, no. 7, pp. 1245–56,
2004.
[79] N. Thawani, M. Tam, M. J. Bellemare, D. S. Bohle, M. Olivier, J. B.
de Souza, and M. M. Stevenson, “Plasmodium products contribute to
severe malarial anemia by inhibiting erythropoietin-induced proliferation
of erythroid precursors,” J Infect Dis, vol. 209, no. 1, pp. 140–9, 2014.
[Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/23922378
115
[80] D. S. Khoury, D. Cromer, J. Akter, I. Sebina, T. Elliott, B. S. Thomas, M. S.
Soon, K. R. James, S. E. Best, A. Haque et al., “Host-mediated impairment
of parasite maturation during blood-stage plasmodium infection,” Proceed-
ings of the National Academy of Sciences, vol. 114, no. 29, pp. 7701–7706,
2017.
[81] N. Mideo, V. C. Barclay, B. H. Chan, N. J. Savill, A. F. Read,
and T. Day, “Understanding and predicting strain-specific patterns
of pathogenesis in the rodent malaria plasmodium chabaudi,” Am
Nat, vol. 172, no. 5, pp. 214–38, 2008. [Online]. Available: http:
//www.journals.uchicago.edu/doi/abs/10.1086/591684
[82] Y. Li, S. Ruan, and D. Xiao, “The within-host dynamics of malaria infection
with immune response,”Math Biosci Eng, vol. 8, no. 4, pp. 999–1018, 2011.
[83] D. Cromer, K. J. Evans, L. Schofield, and M. P. Davenport, “Preferential
invasion of reticulocytes during late-stage plasmodium berghei infection
accounts for reduced circulating reticulocyte levels,” Int J Parasitol,
vol. 36, no. 13, pp. 1389–97, 2006. [Online]. Available: http://www.ncbi.
nlm.nih.gov/pubmed/16979643
[84] L. L. Fonseca and E. O. Voit, “Comparison of mathematical frameworks for
modeling erythropoiesis in the context of malaria infection,”Mathematical
biosciences, vol. 270, pp. 224–236, 2015.
[85] A. Raue, C. Kreutz, T. Maiwald, J. Bachmann, M. Schilling, U. Kling-
muller, and J. Timmer, “Structural and practical identifiability analysis of
partially observed dynamical models by exploiting the profile likelihood,”
Bioinformatics, vol. 25, no. 15, pp. 1923–9, 2009. [Online]. Available:
http://www.ncbi.nlm.nih.gov/pubmed/19505944
[86] J. Berger, “Phenylhydrazine haematotoxicity,” J Appl Biomed, vol. 5, no. 3,
pp. 125–30, 2007.
[87] M. J. Nielsen, H. J. Møller, and S. K. Moestrup, “Hemoglobin and heme
scavenger receptors,” Antioxidants & redox signaling, vol. 12, no. 2, pp.
261–273, 2010.
116
[88] R. Moreau, D. T. Malu, M. Dumais, E. Dalko, V. Gaudreault, H. Roméro,
C. Martineau, O. Kevorkova, J. S. Dardon, E. L. Dodd et al., “Alterations
in bone and erythropoiesis in hemolytic anemia: comparative study in
bled, phenylhydrazine-treated and plasmodium-infected mice,” PLoS One,
vol. 7, no. 9, p. e46101, 2012.
[89] K. Brown and L. Hills, “Recent developments in vaccination against
malaria: The possible role of isoantigens in protective immunity to
malaria,” Bulletin of the World Health Organization, vol. 57, no. Suppl,
p. 135, 1979.
[90] J. L. Spivak, D. Toretti, and H. W. Dickerman, “Effect of phenylhydrazine-
induced hemolytic anemia on nuclear rna polymerase activity of the mouse
spleen,” Blood, vol. 42, no. 2, pp. 257–266, 1973.
[91] C. H. Kim, “Homeostatic and pathogenic extramedullary hematopoiesis,”
Journal of blood medicine, vol. 1, p. 13, 2010.
[92] P. H. Long, “Experimental anemia produced by phenyl-hydrazine deriva-
tives,” The Journal of clinical investigation, vol. 2, no. 4, pp. 329–342,
1926.
[93] N. J. Savill, W. Chadwick, and S. E. Reece, “Quantitative analysis of
mechanisms that govern red blood cell age structure and dynamics during
anaemia,” PLoS computational biology, vol. 5, no. 6, p. e1000416, 2009.
[94] S. K. Jain and P. Hochstein, “Membrane alterations in phenylhydrazine-
induced reticulocytes,” Archives of biochemistry and biophysics, vol. 201,
no. 2, pp. 683–687, 1980.
[95] J. Dreschfeld, “Pyrodin: a new antipyretic,” Br Med J ii, vol. 881, 1888.
[96] C. S. Hopp, B. L. Bennett, S. Mishra, C. Lehmann, K. K. Hanson, J. W.
Lin, K. Rousseau, F. A. Carvalho, W. A. van der Linden, N. C. Santos,
M. Bogyo, S. M. Khan, V. Heussler, and P. Sinnis, “Deletion of the rodent
malaria ortholog for falcipain-1 highlights differences between hepatic and
117
blood stage merozoites,” PLoS Pathog, vol. 13, no. 9, p. e1006586, 2017.
[Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/28922424
[97] A. Srivastava, D. J. Creek, K. J. Evans, D. De Souza, L. Schofield,
S. Muller, M. P. Barrett, M. J. McConville, and A. P. Waters, “Host
reticulocytes provide metabolic reservoirs that can be exploited by malaria
parasites,” PLoS Pathog, vol. 11, no. 6, p. e1004882, 2015. [Online].
Available: http://www.ncbi.nlm.nih.gov/pubmed/26042734
[98] R. Banerjee, S. Khandelwal, Y. Kozakai, B. Sahu, and S. Kumar, “Cd47
regulates the phagocytic clearance and replication of the plasmodium
yoelii malaria parasite,” Proc Natl Acad Sci U S A, vol. 112, no. 10, pp.
3062–7, 2015. [Online]. Available: http://www.ncbi.nlm.nih.gov/pubmed/
25713361
[99] J. Iyer, A. C. Gruner, L. Renia, G. Snounou, and P. R. Preiser, “Invasion
of host cells by malaria parasites: a tale of two protein families,”
Mol Microbiol, vol. 65, no. 2, pp. 231–49, 2007. [Online]. Available:
http://www.ncbi.nlm.nih.gov/pubmed/17630968
[100] M. Lopes da Silva, C. Thieleke-Matos, L. Cabrita-Santos, J. S. Ramalho,
S. T. Wavre-Shapton, C. E. Futter, D. C. Barral, and M. C. Seabra, “The
host endocytic pathway is essential for plasmodium berghei late liver stage
development,” Traffic, vol. 13, no. 10, pp. 1351–1363, 2012.
[101] A. Sturm, R. Amino, C. Van de Sand, T. Regen, S. Retzlaff, A. Rennenberg,
A. Krueger, J.-M. Pollok, R. Menard, and V. T. Heussler, “Manipulation of
host hepatocytes by the malaria parasite for delivery into liver sinusoids,”
science, vol. 313, no. 5791, pp. 1287–1290, 2006.
[102] M. Prudêncio, A. Rodriguez, andM.M.Mota, “The silent path to thousands
of merozoites: the plasmodium liver stage,” Nature Reviews Microbiology,
vol. 4, no. 11, p. 849, 2006.
[103] A. M. Vaughan and S. H. Kappe, “Malaria vaccine development:
persistent challenges,” Current Opinion in Immunology, vol. 24, no. 3,
118
pp. 324 – 331, 2012, lymphocyte activation and effector functions
/ Vaccines. [Online]. Available: http://www.sciencedirect.com/science/
article/pii/S0952791512000556
[104] J. L. Miller, S. Murray, A. M. Vaughan, A. Harupa, B. Sack, M. Baldwin,
I. N. Crispe, and S. H. I. Kappe, “Quantitative bioluminescent imaging
of pre-erythrocytic malaria parasite infection using luciferase-expressing
plasmodium yoelii,” PLOS ONE, vol. 8, no. 4, pp. 1–9, 04 2013. [Online].
Available: https://doi.org/10.1371/journal.pone.0060820
[105] R. J. Longley, A. V. Hill, and A. J. Spencer, “Malaria vaccines: identify-
ing plasmodium falciparum liver-stage targets,” Frontiers in microbiology,
vol. 6, p. 965, 2015.
[106] B. Wizel, R. A. Houghten, K. C. Parker, J. E. Coligan, P. Church, D. M.
Gordon, W. R. Ballou, and S. L. Hoffman, “Irradiated sporozoite vac-
cine induces hla-b8-restricted cytotoxic t lymphocyte responses against two
overlapping epitopes of the plasmodium falciparum sporozoite surface pro-
tein 2.” Journal of Experimental Medicine, vol. 182, no. 5, pp. 1435–1445,
1995.
[107] M. Tsuji, “A retrospective evaluation of the role of t cells in the development
of malaria vaccine,” Experimental parasitology, vol. 126, no. 3, pp. 421–
425, 2010.
[108] J. Ezaki, N. Matsumoto, M. Takeda-Ezaki, M. Komatsu, K. Takahashi,
Y. Hiraoka, H. Taka, T. Fujimura, K. Takehana, M. Yoshida et al., “Liver
autophagy contributes to the maintenance of blood glucose and amino acid
levels,” Autophagy, vol. 7, no. 7, pp. 727–736, 2011.
[109] C. Agop-Nersesian, M. De Niz, L. Niklaus, M. Prado, N. Eickel, and V. T.
Heussler, “Shedding of host autophagic proteins from the parasitophorous
vacuolar membrane of plasmodium berghei,” Scientific Reports, vol. 7,
no. 1, p. 2191, 2017.
119
[110] M. Hösel, A. Huber, S. Bohlen, J. Lucifora, G. Ronzitti, F. Puzzo, F. Bois-
gerault, U. T. Hacker, W. J. Kwanten, N. Klöting et al., “Autophagy deter-
mines efficiency of liver-directed gene therapy with adeno-associated viral
vectors,” Hepatology, vol. 66, no. 1, pp. 252–265, 2017.
[111] G. Zaffagnini and S. Martens, “Mechanisms of selective autophagy,”
Journal of Molecular Biology, vol. 428, no. 9, Part A, pp. 1714 – 1724,
2016, molecular Mechanisms of Autophagy, Part A. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/S0022283616001091
[112] A. Kuma, M. Hatano, M. Matsui, A. Yamamoto, H. Nakaya, T. Yoshimori,
Y. Ohsumi, T. Tokuhisa, and N. Mizushima, “The role of autophagy during
the early neonatal starvation period,” Nature, vol. 432, no. 7020, p. 1032,
2004.
[113] A. M. Vaughan, A. S. Aly, and S. H. Kappe, “Malaria parasite pre-
erythrocytic stage infection: gliding and hiding,” Cell host & microbe,
vol. 4, no. 3, pp. 209–218, 2008.
[114] C. M. Schworer, K. Shiffer, and G. Mortimore, “Quantitative relationship
between autophagy and proteolysis during graded amino acid deprivation
in perfused rat liver.” Journal of Biological Chemistry, vol. 256, no. 14, pp.
7652–7658, 1981.
[115] G. E. Mortimore, N. J. Hutson, and C. A. Surmacz, “Quantitative corre-
lation between proteolysis and macro-and microautophagy in mouse hep-
atocytes during starvation and refeeding,” Proceedings of the National
Academy of Sciences, vol. 80, no. 8, pp. 2179–2183, 1983.
[116] L. Mancio-Silva, K. Slavic, M. T. G. Ruivo, A. R. Grosso, K. K. Modrzyn-
ska, I. M. Vera, J. Sales-Dias, A. R. Gomes, C. R. MacPherson, P. Crozet
et al., “Nutrient sensing modulates malaria parasite virulence,” Nature, vol.
547, no. 7662, p. 213, 2017.
[117] M. Tseng and J. H. Myers, “The relationship between parasite fitness and
host condition in an insect - virus system,” PLOS ONE, vol. 8, no. 4, pp.
120
1–9, 09 2014. [Online]. Available: https://doi.org/10.1371/journal.pone.
0106401
[118] L. Lim and G. I. McFadden, “The evolution, metabolism and functions of
the apicoplast,” Philosophical Transactions of the Royal Society B: Biolog-
ical Sciences, vol. 365, no. 1541, pp. 749–763, 2010.
[119] C. D. Goodman and G. I. McFadden, “Targeting apicoplasts in malaria
parasites,” Expert Opinion on Therapeutic Targets, vol. 17, no. 2, pp.
167–177, 2013. [Online]. Available: https://doi.org/10.1517/14728222.
2013.739158
[120] G. I. McFadden, “Apicoplast,” Current Biology, vol. 24, no. 7, pp. R262
– R263, 2014. [Online]. Available: http://www.sciencedirect.com/science/
article/pii/S0960982214000256
[121] T. A. Dellibovi-Ragheb, H. Jhun, C. D. Goodman, M. S. Walters, D. R.
Ragheb, K. A. Matthews, K. Rajaram, S. Mishra, G. I. McFadden, P. Sinnis
et al., “Host biotin is required for liver stage development in malaria para-
sites,” Proceedings of the National Academy of Sciences, vol. 115, no. 11,
pp. E2604–E2613, 2018.
[122] Y. Wang, L. M. Weiss, and A. Orlofsky, “Host cell autophagy is induced by
toxoplasma gondii and contributes to parasite growth,” Journal of Biologi-
cal Chemistry, vol. 284, no. 3, pp. 1694–1701, 2009.
[123] J. Laliberte and V. B. Carruthers, “Host cell manipulation by the human
pathogen toxoplasma gondii,” Cellular and molecular life sciences, vol. 65,
no. 12, pp. 1900–1915, 2008.
[124] I. Clark and K. Rockett, “The cytokine theory of human cerebral malaria,”
Parasitology Today, vol. 10, no. 10, pp. 410–412, 1994.
[125] A. Berendt, G. Tumer, and C. Newbold, “Cerebral malaria: the sequestra-
tion hypothesis,” Parasitology Today, vol. 10, no. 10, pp. 412–414, 1994.
121
[126] W. S. Crocodile, M. C. Alan, T. Terrie, G. G. Emile, M. M. Edward, and
C. A. Gordon, “Vascular endothelial cells cultured from patients with cere-
bral or uncomplicated malaria exhibit differential reactivity to tnf,”Cellular
Microbiology, vol. 13, no. 2, pp. 198–209, 2010.
[127] N. A. Beare, S. P. Harding, T. E. Taylor, S. Lewallen, and M. E. Molyneux,
“Perfusion abnormalities in children with cerebral malaria and malarial
retinopathy,” The Journal of infectious diseases, vol. 199, no. 2, pp. 263–
271, 2009.
[128] J. Storm and A. G. Craig, “Pathogenesis of cerebral malaria—inflammation
and cytoadherence,” Frontiers in Cellular and Infection Microbiology,
vol. 4, p. 100, 2014. [Online]. Available: https://www.frontiersin.org/
article/10.3389/fcimb.2014.00100
[129] R. M. Fairhurst, C. D. Bess, and M. A. Krause, “Abnormal pfemp1/knob
display on plasmodium falciparum-infected erythrocytes containing
hemoglobin variants: fresh insights into malaria pathogenesis and protec-
tion,”Microbes and infection, vol. 14, no. 10, pp. 851–862, 2012.
[130] N. J. White, G. D. Turner, N. P. Day, and A. M. Dondorp, “Lethal malaria:
Marchiafava and bignami were right,” The Journal of infectious diseases,
vol. 208, no. 2, pp. 192–198, 2013.
[131] T. W. Yeo, D. A. Lampah, E. Tjitra, K. Piera, R. Gitawati, E. Kenangalem,
R. N. Price, and N. M. Anstey, “Greater endothelial activation, weibel-
palade body release and host inflammatory response to plasmodium vivax,
compared with plasmodium falciparum: a prospective study in papua, in-
donesia,” The Journal of infectious diseases, vol. 202, no. 1, pp. 109–112,
2010.
[132] G. E. Grau, T. E. Taylor, M. E.Molyneux, J. J. Wirima, P. Vassalli, M. Hom-
mel, and P.-H. Lambert, “Tumor necrosis factor and disease severity in chil-
dren with falciparum malaria,” New England journal of medicine, vol. 320,
no. 24, pp. 1586–1591, 1989.
122
[133] M. A. Hall, “Correlation-based feature selection for machine learning,”
Ph.D. dissertation, University of Waikato Hamilton, 1999.
[134] A. Villegas-Mendez, R. Greig, T. N. Shaw, J. B. de Souza, E. G. Findlay,
J. S. Stumhofer, J. C. Hafalla, D. G. Blount, C. A. Hunter, E. M. Riley
et al., “Ifn-γ–producing cd4+ t cells promote experimental cerebral malaria
by modulating cd8+ t cell accumulation within the brain,” The Journal of
Immunology, p. 1200688, 2012.
[135] J. Nitcheu, O. Bonduelle, C. Combadiere, M. Tefit, D. Seilhean, D. Mazier,
and B. Combadiere, “Perforin-dependent brain-infiltrating cytotoxic cd8+
t lymphocytes mediate experimental cerebral malaria pathogenesis,” The
Journal of Immunology, vol. 170, no. 4, pp. 2221–2228, 2003.
[136] D. M. Yanez, D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. Van
Der Heyde, “Participation of lymphocyte subpopulations in the pathogene-
sis of experimental murine cerebral malaria.” The Journal of Immunology,
vol. 157, no. 4, pp. 1620–1624, 1996.
[137] E. Belnoue, M. Kayibanda, A. M. Vigario, J.-C. Deschemin, N. van Rooi-
jen, M.Viguier, G. Snounou, and L. Rénia, “On the pathogenic role of brain-
sequestered αβ cd8+ t cells in experimental cerebral malaria,” The Journal
of Immunology, vol. 169, no. 11, pp. 6369–6375, 2002.
[138] L. Yu and H. Liu, “Feature selection for high-dimensional data: A fast
correlation-based filter solution,” in Proceedings of the 20th international
conference on machine learning (ICML-03), 2003, pp. 856–863.
[139] L. Piva, P. Tetlak, C. Claser, K. Karjalainen, L. Renia, and C. Ruedl, “Cut-
ting edge: Clec9a+ dendritic cells mediate the development of experimental
cerebral malaria,” The Journal of Immunology, vol. 189, no. 3, pp. 1128–
1132, 2012.
[140] G. S. Campanella, A. M. Tager, J. K. El Khoury, S. Y. Thomas, T. A.
Abrazinski, L. A. Manice, R. A. Colvin, and A. D. Luster, “Chemokine
123
receptor cxcr3 and its ligands cxcl9 and cxcl10 are required for the devel-
opment of murine cerebral malaria,” Proceedings of the National Academy
of Sciences, vol. 105, no. 12, pp. 4814–4819, 2008.
[141] J. Miu, A. J. Mitchell, M.Müller, S. L. Carter, P. M.Manders, J. A. McQuil-
lan, B. M. Saunders, H. J. Ball, B. Lu, I. L. Campbell et al., “Chemokine
gene expression during fatal murine cerebral malaria and protection due to
cxcr3 deficiency,” The Journal of Immunology, vol. 180, no. 2, pp. 1217–
1230, 2008.
[142] S. W. Howland, C. Claser, C. M. Poh, S. Y. Gun, and L. Rénia,
“Pathogenic cd8+ t cells in experimental cerebral malaria,” in Seminars in
immunopathology, vol. 37, no. 3. Springer, 2015, pp. 221–231.
[143] T. N. Shaw, P. J. Stewart-Hutchinson, P. Strangward, D. B. Dandamudi,
J. A. Coles, A. Villegas-Mendez, J. Gallego-Delgado, N. van Rooijen,
E. Zindy, A. Rodriguez et al., “Perivascular arrest of cd8+ t cells is a sig-
nature of experimental cerebral malaria,” PLoS pathogens, vol. 11, no. 11,
p. e1005210, 2015.
[144] F. G. Baptista, A. Pamplona, A. C. Pena, M. M. Mota, S. Pied, and A. M.
Vigário, “Accumulation of plasmodium berghei-infected red blood cells in
the brain is crucial for the development of cerebral malaria in mice,” Infec-
tion and immunity, vol. 78, no. 9, pp. 4033–4039, 2010.
[145] K. H. Chang, M. Tam, and M. M. Stevenson, “Modulation of the
course and outcome of blood-stage malaria by erythropoietin-induced
reticulocytosis,” J Infect Dis, vol. 189, no. 4, pp. 735–43, 2004. [Online].
Available: http://www.ncbi.nlm.nih.gov/pubmed/14767829
